Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  HIV Infection

  Free Subscription


Articles published in J Acquir Immune Defic Syndr

Retrieve available abstracts of 489 articles:
HTML format
Text format



Single Articles


    April 2010
  1. JONES R , Nelson M, Low E, Atkins M, et al
    Re-emergent Hepatitis C Viremia After Apparent Clearance in HIV-Positive Men Who Have Sex With Men: Reinfection or Late Recurrence?
    J Acquir Immune Defic Syndr. 2010;53:547-50.
    PubMed     Text format     Related articles   


  2. TAN CK , Hung CC, Lai CC, Liao CH, et al
    Diagnosis of Active Tuberculosis by Enzyme-Linked Immunospot Assay for Interferon-gamma in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2010;53:546-7.
    PubMed     Text format     Related articles   


  3. PROTOPOPESCU C , Roux P, Carrieri MP, Katlama C, et al
    Prolonged Medically Recorded Treatment Interruptions Among HIV-Infected Patients on Highly Active Antiretroviral Therapy With Controlled Viremia: When Physicians Have to Juggle Patient Negotiation and Guidelines.
    J Acquir Immune Defic Syndr. 2010;53:544-545.
    PubMed     Text format     Related articles   


    March 2010
  4. NYANDIKO WM , Otieno-Nyunya B, Musick B, Bucher-Yiannoutsos S, et al
    Outcomes of HIV-Exposed Children in Western Kenya: Efficacy of Prevention of Mother to Child Transmission in a Resource-Constrained Setting.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  5. ANDRADE RM , Andrade AF, Lazaro MA, Vieira MM, et al
    Failure of Highly Active Antiretroviral Therapy in Reconstituting Immune Response to Clostridium tetani Vaccine in Aged AIDS Patients.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  6. CHEN YQ , Young A, Brown ER, Chasela CS, et al
    Population Attributable Fractions for Late Postnatal Mother-to-Child Transmission of HIV-1 in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  7. HOFFMAN RM , Black V, Technau K, van der Merwe KJ, et al
    Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  8. EMMETT SD , Cunningham CK, Mmbaga BT, Kinabo GD, et al
    Predicting Virologic Failure Among HIV-1-Infected Children Receiving Antiretroviral Therapy in Tanzania: a Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  9. DEFFENBACHER KE , Iqbal J, Liu Z, Fu K, et al
    Recurrent Chromosomal Alterations in Molecularly Classified AIDS-Related Lymphomas: An Integrated Analysis of DNA Copy Number and Gene Expression.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  10. CHRISTOPOULOS KA , Schackman BR, Lee G, Green RA, et al
    Results From a New York City Emergency Department Rapid HIV Testing Program.
    J Acquir Immune Defic Syndr. 2010;53:420-422.
    PubMed     Text format     Related articles   


  11. BAEKKEN M , Manner I, Ueland T, Froland SS, et al
    Osteoprotegrin and Soluble Tumor Necrosis Factor Receptor 1 Are Associated With Microalbuminuria in Nontreated HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2010;53:419-420.
    PubMed     Text format     Related articles   


  12. SONG JY , Lee JS, Jung HW, Choi HJ, et al
    Herpes Zoster Among HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era: Korean HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2010;53:417-8.
    PubMed     Text format     Related articles   


  13. KEW MC , Smuts H, Stewart A
    Does HIV Infection Enhance the Hepatocarcinogenic Potential of Chronic Hepatitis B Virus Infection?
    J Acquir Immune Defic Syndr. 2010;53:413-4.
    PubMed     Text format     Related articles   


  14. RUPP D , Geuenich S, Keppler OT
    Poor Performance of Bioinformatics Programs for Genotypic Prediction of Coreceptor Usage of HIV-1 Group O Isolates.
    J Acquir Immune Defic Syndr. 2010;53:412-3.
    PubMed     Text format     Related articles   


  15. KOBLIN BA , Bonner S, Hoover DR, Xu G, et al
    A Randomized Trial of Enhanced HIV Risk-Reduction and Vaccine Trial Education Interventions Among HIV-Negative, High-Risk Women Who Use Noninjection Drugs: The UNITY Study.
    J Acquir Immune Defic Syndr. 2010;53:378-87.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  16. HOWARD AA , Hoover DR, Anastos K, Wu X, et al
    The Effects of Opiate Use and Hepatitis C Virus Infection on Risk of Diabetes Mellitus in the Women's Interagency HIV Study.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  17. SCHACKER TW , Bosch RJ, Bennett K, Pollard R, et al
    Measurement of Naive CD4 Cells Reliably Predicts Potential for Immune Reconstitution in HIV.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  18. LIEB S , White S, Grigg BL, Thompson DR, et al
    Estimated HIV Incidence, Prevalence, and Mortality Rates Among Racial/Ethnic Populations of Men Who Have Sex with Men, Florida.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  19. WILSON TE , Jean-Louis G, Schwartz R, Golub ET, et al
    HIV Infection and Women's Sexual Functioning.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  20. WEVER K , van Agtmael MA, Carr A
    Incomplete Reversibility of Tenofovir-Related Renal Toxicity in HIV-Infected Men.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  21. BELL C , Metsch LR, Vogenthaler N, Cardenas G, et al
    Never in Care: Characteristics of HIV-Infected Crack Cocaine Users in 2 US Cities Who Have Never Been to Outpatient HIV Care.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  22. PROMADEJ-LANIER N , Hanson DL, Srinivasan P, Luo W, et al
    Resistance to Simian HIV Infection Is Associated With High Plasma Interleukin-8, RANTES and Eotaxin in a Macaque Model of Repeated Virus Challenges.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  23. MANTINA H , Wiggill TM, Carmona S, Perner Y, et al
    Characterization of Lymphomas in a High Prevalence HIV Setting.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  24. LAMPE FC , Harding R, Smith CJ, Phillips AN, et al
    Physical and Psychological Symptoms and Risk of Virologic Rebound Among Patients With Virologic Suppression on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  25. DEOK-JONG YOO S , Worodria W, Davis JL, Cattamanchi A, et al
    The Prevalence and Clinical Course of HIV-Associated Pulmonary Cryptococcosis in Uganda.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  26. VIEILLARD V , Fausther-Bovendo H, Samri A, Debre P, et al
    Specific Phenotypic and Functional Features of Natural Killer Cells From HIV-Infected Long-Term Nonprogressors and HIV Controllers.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  27. SCOTT-ALGARA D , Rouzioux C, Blanche S, Burgard M, et al
    In Untreated HIV-1-Infected Children, PBMC-Associated HIV DNA Levels and Cell-Free HIV RNA Levels Are Correlated to Distinct T-lymphocyte Populations.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  28. DAU B , Ayers D, Singer J, Richard Harrigan P, et al
    Connection Domain Mutations in Treatment-Experienced Patients in the OPTIMA Trial.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  29. CHEN YJ , Huang YH, Chuang SY, Kao DY, et al
    Molecular Epidemiology of HIV-1 Subtype B, CRF01_AE, and CRF07_BC Infection Among Injection Drug Users in Taiwan.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  30. HILLIS SD , Phd EK, Akatova N, Kissin DM, et al
    Antiretroviral Prophylaxis to Prevent Perinatal HIV Transmission in St. Petersburg, Russia: Too Little, Too Late.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  31. PARA MF , Schouten J, Rosenkranz SL, Yu S, et al
    Phase I/II Trial of the Anti-HIV Activity of Mifepristone in HIV-Infected Subjects ACTG 5200.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  32. ZAJDENVERG R , Podsadecki TJ, Badal-Faesen S, Andrade-Villanueva J, et al
    Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1-Infected Subjects at 48 Weeks.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  33. TOWNER W , Lalezari J, Sension MG, Wohlfeiler M, et al
    Efficacy, Safety, and Tolerability of Etravirine With and Without Darunavir/Ritonavir or Raltegravir in Treatment-Experienced Patients: Analysis of the Etravirine Early Access Program in the United States.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  34. GUARALDI G , Stentarelli C, Orlando G, Zona S, et al
    Nonalcoholic Fatty Liver Disease in HIV-Infected Persons: Epidemiology and the Role of Nucleoside Reverse Transcriptase Inhibitors.
    J Acquir Immune Defic Syndr. 2010;53:278.
    PubMed     Text format     Related articles   


  35. CRUM-CIANFLONE N , Dilay A, Collins G, Asher D, et al
    Reply to "Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons".
    J Acquir Immune Defic Syndr. 2010;53:278-81.
    PubMed     Text format     Related articles   


  36. YE Y , Zeng Y, Li X, Zhang S, et al
    HIV Infection: An Independent Risk Factor of Peripheral Arterial Disease.
    J Acquir Immune Defic Syndr. 2010;53:276-8.
    PubMed     Text format     Related articles   


  37. KHEIRANDISH P , Seyedalinaghi SA, Hosseini M, Jahani MR, et al
    Prevalence and Correlates of HIV Infection Among Male Injection Drug Users in Detention in Tehran, Iran.
    J Acquir Immune Defic Syndr. 2010;53:273-275.
    PubMed     Text format     Related articles    Abstract available


  38. KACANEK D , Jacobson DL, Spiegelman D, Wanke C, et al
    Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the nutrition for healthy living study.
    J Acquir Immune Defic Syndr. 2010;53:266-72.
    PubMed     Text format     Related articles    Abstract available


  39. FISCHER MJ , Wyatt CM, Gordon K, Gibert CL, et al
    Hepatitis C and the Risk of Kidney Disease and Mortality in Veterans With HIV.
    J Acquir Immune Defic Syndr. 2010;53:222-226.
    PubMed     Text format     Related articles    Abstract available


  40. WILLIG JH , Echevarria J, Westfall AO, Iglesias D, et al
    Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for Zidovudine weight-based dosing.
    J Acquir Immune Defic Syndr. 2010;53:215-21.
    PubMed     Text format     Related articles    Abstract available


  41. JOAO EC , Calvet GA, Krauss MR, Freimanis Hance L, et al
    Maternal Antiretroviral Use During Pregnancy and Infant Congenital Anomalies: The NISDI Perinatal Study.
    J Acquir Immune Defic Syndr. 2010;53:176-185.
    PubMed     Text format     Related articles    Abstract available


  42. FENG Y , Wu Z, Detels R
    Evolution of men who have sex with men community and experienced stigma among men who have sex with men in Chengdu, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S98-103.
    PubMed     Text format     Related articles    Abstract available


  43. WANG Y , Jiang Y, Lu L, Wang G, et al
    Microbicide acceptability and associated factors among female sex workers and male clients in kaiyuan county, yunnan province, china.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S93-7.
    PubMed     Text format     Related articles    Abstract available


  44. ZHANG H , Wu Z, Zheng Y, Wang J, et al
    A pilot intervention to increase condom use and HIV testing and counseling among men who have sex with men in Anhui, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S88-92.
    PubMed     Text format     Related articles    Abstract available


  45. ZOU H , Wu Z, Yu J, Li M, et al
    Sexual risk behaviors and HIV infection among men who have sex with men who use the internet in Beijing and Urumqi, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S81-7.
    PubMed     Text format     Related articles    Abstract available


  46. FENG Y , Wu Z, Detels R, Qin G, et al
    HIV/STD prevalence among men who have sex with men in Chengdu, China and associated risk factors for HIV infection.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S74-80.
    PubMed     Text format     Related articles    Abstract available


  47. XIAO Y , Sun J, Li C, Lu F, et al
    Prevalence and correlates of HIV and syphilis infections among men who have sex with men in seven provinces in China with historically low HIV prevalence.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S66-73.
    PubMed     Text format     Related articles    Abstract available


  48. WANG L , Liu W, Wang L, Wang Y, et al
    HIV prevalence among pulmonary tuberculosis patients in Guangxi, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S61-5.
    PubMed     Text format     Related articles    Abstract available


  49. ZHANG G , Wong M, Yi P, Xu J, et al
    HIV-1 and STIs prevalence and risk factors of miners in mining districts of Yunnan, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S54-60.
    PubMed     Text format     Related articles    Abstract available


  50. LI Y , Detels R, Lin P, Fu X, et al
    Prevalence of HIV and STIs and associated risk factors among female sex workers in Guangdong Province, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S48-53.
    PubMed     Text format     Related articles    Abstract available


  51. LI N , Wang Z, Sun D, Zhu Q, et al
    HIV among plasma donors and other high-risk groups in Henan, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S41-7.
    PubMed     Text format     Related articles    Abstract available


  52. ZHAO M , Geng W, Jiang Y, Han X, et al
    The associations of hA3G and hA3B mRNA levels with HIV disease progression among HIV-infected individuals of China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S4-9.
    PubMed     Text format     Related articles    Abstract available


  53. JIA M , Luo H, Ma Y, Wang N, et al
    The HIV epidemic in Yunnan Province, China, 1989-2007.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S34-40.
    PubMed     Text format     Related articles    Abstract available


  54. HAN X , Dai D, Zhao B, Liu J, et al
    Genetic and epidemiologic characterization of HIV-1 infection In Liaoning Province, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S27-33.
    PubMed     Text format     Related articles    Abstract available


  55. ZHOU Z , Meyers K, Li X, Chen Q, et al
    Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S15-22.
    PubMed     Text format     Related articles    Abstract available


  56. XU T , Wu Z, Yan Z, Rou K, et al
    Measuring health-related quality of life in children living in HIV/AIDS-affected families in rural areas in Yunnan, China: Preliminary reliability and validity of the Chinese version of PedsQL 4.0 generic core scales.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S111-5.
    PubMed     Text format     Related articles    Abstract available


  57. XU T , Wu Z, Duan S, Han W, et al
    The situation of children affected by HIV/AIDS in Southwest China: Schooling, physical health, and interpersonal relationships.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S104-10.
    PubMed     Text format     Related articles    Abstract available


  58. LIAO L , Xing H, Shang H, Li J, et al
    The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S10-4.
    PubMed     Text format     Related articles    Abstract available


  59. WU Z , Wang Y
    Introduction: China meets new AIDS challenges.
    J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S1-3.
    PubMed     Text format     Related articles   


    January 2010
  60. LABARGA P , Vispo E, Barreiro P, Rodriguez-Novoa S, et al
    Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/HCV-Coinfected Patients With Prior Nonresponse or Relapse.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  61. OSINUSI A , Rasimas JJ, Bishop R, Proschan M, et al
    HIV/Hepatitis C Virus-Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders Do.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  62. FALUTZ J , Potvin D, Mamputu JC, Assaad H, et al
    Effects of Tesamorelin, a Growth Hormone-Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  63. HENDRICKSON SL , Jabs DA, Van Natta M, Lewis RA, et al
    Mitochondrial Haplogroups Are Associated With Risk of Neuroretinal Disorder in HIV-Positive Patients.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  64. WYATT CM , Hoover DR, Shi Q, Seaberg E, et al
    Microalbuminuria Is Associated With All-Cause and AIDS Mortality in Women With HIV Infection.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  65. SIERRA-MADERO J , Villasis-Keever A, Mendez P, Mosqueda-Gomez JL, et al
    Prospective, Randomized, Open Label Trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ Treatment-Naive Subjects With CD4+<200 cell/mm3 in Mexico.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  66. NIE J , Zhang C, Liu W, Wu X, et al
    Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 CRF01_AE env Molecular Clones From Infections in China.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  67. COOPER V , Horne R, Gellaitry G, Vrijens B, et al
    The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAART on Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  68. CRAWFORD KW , Li C, Keung A, Su Z, et al
    Pharmacokinetic/Pharmacodynamic Modeling of the Antiretroviral Activity of the CCR5 Antagonist Vicriviroc in Treatment Experienced HIV-Infected Subjects (ACTG Protocol 5211).
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  69. KATZ IT , Shapiro R, Li D, Govindarajulu U, et al
    Risk Factors for Detectable HIV-1 RNA at Delivery Among Women Receiving Highly Active Antiretroviral Therapy in the Women and Infants Transmission Study.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  70. CHANG TL , Klepper A, Ding J, Garber J, et al
    Human Peritoneal Macrophages From Ascitic Fluid Can be Infected by a Broad Range of Human Immunodeficiency Virus Type 1 Isolates.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  71. HURT CB , Matthews DD, Calabria MS, Green KA, et al
    Sex with Older Partners Is Associated With Primary HIV Infection Among Men Who Have Sex With Men in North Carolina.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  72. FISER AL , Lin YL, Portales P, Mettling C, et al
    Pairwise Comparison of Isogenic HIV-1 Viruses: R5 Phenotype Replicates More Efficiently Than X4 Phenotype in Primary CD4+ T Cells Expressing Physiological Levels of CXCR4.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  73. WANG H , Zhuang K, Liu L, Tang Z, et al
    Acute Infection of Chinese Macaques by a CCR5-Tropic SHIV Carrying a Primary HIV-1 Subtype B' Envelope.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


  74. BROGLY SB , Foca M, Deville JG, Mirochnick M, et al
    Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.
    J Acquir Immune Defic Syndr. 2010;53:154-7.
    PubMed     Text format     Related articles   


  75. ZACCARELLI M , Antinori A, Cozzi-Lepri A, Mussini C, et al
    Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test.
    J Acquir Immune Defic Syndr. 2010;53:150-1.
    PubMed     Text format     Related articles   


  76. BRADY MT , Oleske JM, Williams PL, Elgie C, et al
    Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
    J Acquir Immune Defic Syndr. 2010;53:86-94.
    PubMed     Text format     Related articles    Abstract available


  77. TUBOI SH , Pacheco AG, Harrison LH, Stone RA, et al
    Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.
    J Acquir Immune Defic Syndr. 2010;53:70-7.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  78. WILSON IB , Barton Laws M, Safren SA, Lee Y, et al
    Provider-Focused Intervention Increases Adherence-Related Dialogue but Does Not Improve Antiretroviral Therapy Adherence in Persons With HIV.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  79. ERIKSTRUP C , Kronborg G, Lohse N, Rye Ostrowski S, et al
    T-Cell Dysfunction in HIV-1-Infected Patients With Impaired Recovery of CD4 Cells Despite Suppression of Viral Replication.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  80. BEGIER EM , Bennani Y, Forgione L, Punsalang A, et al
    Undiagnosed HIV Infection Among New York City Jail Entrants, 2006: Results of a Blinded Serosurvey.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  81. MOLINA JM , Andrade-Villanueva J, Echevarria J, Chetchotisakd P, et al
    Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Stud
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  82. ZHOU S , Zhao Y, He Y, Li H, et al
    Hepatitis B and Hepatitis C Seroprevalence in Children Receiving Antiretroviral Therapy for Human Immunodeficiency Virus-1 Infection in China, 2005-2009.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  83. GOETZ MB , Leduc R, Wyman N, Kostman JR, et al
    HIV Replication Capacity Is an Independent Predictor of Disease Progression in Persons With Untreated Chronic HIV Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  84. BECKWITH CG , Liu T, Bazerman LB, Delong AK, et al
    HIV Risk Behavior Before and After HIV Counseling and Testing in Jail: A Pilot Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  85. GLASS TR , Battegay M, Cavassini M, De Geest S, et al
    Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  86. KIWANUKA N , Robb M, Laeyendecker O, Kigozi G, et al
    HIV-1 Viral Subtype Differences in the Rate of CD4+ T-Cell Decline Among HIV Seroincident Antiretroviral Naive Persons in Rakai District, Uganda.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  87. ASMUTH DM , Goodrich J, Cooper DA, Haubrich R, et al
    CD4+ T-Cell Restoration After 48 Weeks in the Maraviroc Treatment-Experienced Trials MOTIVATE 1 and 2.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  88. FREIBERG MS , McGinnis KA, Kraemer K, Samet JH, et al
    The Association Between Alcohol Consumption and Prevalent Cardiovascular Diseases Among HIV-Infected and HIV-Uninfected Men.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  89. LIGHTFOOT M , Rotheram-Borus MJ, Comulada WS, Reddy VS, et al
    Efficacy of Brief Interventions in Clinical Care Settings for Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  90. IARIKOV DE , Irizarry-Acosta M, Martorell C, Rauch CA, et al
    Use of HIV Resistance Testing After Prolonged Treatment Interruption.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  91. ENGELS EA , Pfeiffer RM, Landgren O, Moore RD, et al
    Immunologic and Virologic Predictors of AIDS-Related Non-Hodgkin Lymphoma in the Highly Active Antiretroviral Therapy Era.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  92. RAYMOND S , Delobel P, Mavigner M, Ferradini L, et al
    Prediction of HIV Type 1 Subtype C Tropism by Genotypic Algorithms Built From Subtype B Viruses.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  93. PANOS G , Farouk L, Stebbing J, Holmes P, et al
    Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV.
    J Acquir Immune Defic Syndr. 2009;52:525-7.
    PubMed     Text format     Related articles   


  94. SIMONI JM , Huh D, Frick PA, Pearson CR, et al
    Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2009;52:465-473.
    PubMed     Text format     Related articles    Abstract available


  95. BOGER MS , Shintani A, Redhage LA, Mitchell V, et al
    Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.
    J Acquir Immune Defic Syndr. 2009;52:480-7.
    PubMed     Text format     Related articles    Abstract available


  96. BOLIVAR H , Geffin R, Manzi G, Fischl MA, et al
    The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain.
    J Acquir Immune Defic Syndr. 2009;52:659-61.
    PubMed     Text format     Related articles   


  97. TORNERO C , Mafe C
    Varenicline and Antiretroviral Therapy in Patients With HIV.
    J Acquir Immune Defic Syndr. 2009;52:656.
    PubMed     Text format     Related articles   


  98. ESTEBAN PM , Thahn TG, Bravo JF, Roca LK, et al
    Malnutrition Associated With Increased Risk of Peripheral Neuropathy in Peruvian Children With HIV Infection.
    J Acquir Immune Defic Syndr. 2009;52:656-658.
    PubMed     Text format     Related articles   


  99. STEVENS WS , Wallis CL, Sanne I, Venter F, et al
    Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa?
    J Acquir Immune Defic Syndr. 2009;52:655-6.
    PubMed     Text format     Related articles   


  100. BOGART LM , Wagner G, Galvan FH, Banks D, et al
    Conspiracy Beliefs About HIV Are Related to Antiretroviral Treatment Nonadherence Among African American Men With HIV.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  101. WOMACK JA , Scherzer R, Cole SR, Fennie K, et al
    Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection.
    J Acquir Immune Defic Syndr. 2009;52:581-7.
    PubMed     Text format     Related articles    Abstract available


  102. MUSOKE PM , Barlow-Mosha L, Bagenda D, Mudiope P, et al
    Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth.
    J Acquir Immune Defic Syndr. 2009;52:560-8.
    PubMed     Text format     Related articles    Abstract available


  103. HAN J , Wang B, Han N, Zhao Y, et al
    CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients.
    J Acquir Immune Defic Syndr. 2009;52:553-9.
    PubMed     Text format     Related articles    Abstract available


  104. PEERSMAN G , Ferguson L, Torres MA, Smith S, et al
    Increasing civil society participation in the national HIV response: the role of UNGASS reporting.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S97-103.
    PubMed     Text format     Related articles    Abstract available


  105. PEERSMAN G , Rugg D, Erkkola T, Kiwango E, et al
    Are the investments in national HIV monitoring and evaluation systems paying off?
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S87-96.
    PubMed     Text format     Related articles    Abstract available


  106. WARNER-SMITH M , Rugg D, Frescura L, Moussavi S, et al
    Monitoring the 2001 Declaration of Commitment on HIV/AIDS.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S77-86.
    PubMed     Text format     Related articles    Abstract available


  107. RUGG D , Marais H, Carael M, De Lay P, et al
    Are we on course for reporting on the Millennium Development Goals in 2015?
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S69-76.
    PubMed     Text format     Related articles    Abstract available


  108. MAHY M , Warner-Smith M, Stanecki KA, Ghys PD, et al
    Measuring the impact of the global response to the AIDS epidemic: challenges and future directions.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S152-9.
    PubMed     Text format     Related articles    Abstract available


  109. ADAM PC , de Wit JB, Toskin I, Mathers BM, et al
    Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S143-51.
    PubMed     Text format     Related articles    Abstract available


  110. MATHERS BM , Degenhardt L, Adam P, Toskin I, et al
    Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S132-42.
    PubMed     Text format     Related articles    Abstract available


  111. TAKEI T , Amin NA, Schmid G, Dhingra-Kumar N, et al
    Progress in global blood safety for HIV.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S127-31.
    PubMed     Text format     Related articles    Abstract available


  112. IZAZOLA-LICEA JA , Wiegelmann J, Aran C, Guthrie T, et al
    Financing the response to HIV in low-income and middle-income countries.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S119-26.
    PubMed     Text format     Related articles    Abstract available


  113. CARAEL M , Marais H, Polsky J, Mendoza A, et al
    Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S111-8.
    PubMed     Text format     Related articles    Abstract available


  114. GRUSKIN S , Ferguson L, Peersman G, Rugg D, et al
    Human rights in the global response to HIV: findings from the 2008 United Nations General Assembly Special Session Reports.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 2:S104-10.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  115. BERNSTEIN KT , Marcus JL, Nieri G, Philip SS, et al
    Rectal Gonorrhea and Chlamydia Reinfection Is Associated With Increased Risk of HIV Seroconversion.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  116. KUMTA S , Lurie M, Weitzen S, Jerajani H, et al
    Bisexuality, Sexual Risk Taking, and HIV Prevalence Among Men Who Have Sex With Men Accessing Voluntary Counseling and Testing Services in Mumbai, India.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  117. MOSIMANEOTSILE B , Mathoma A, Chengeta B, Nyirenda S, et al
    Isoniazid Tuberculosis Preventive Therapy in HIV-Infected Adults Accessing Antiretroviral Therapy: A Botswana Experience, 2004-2006.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  118. OTITI-SENGERI J , Colebunders R, Kempen JH, Ronald A, et al
    The Prevalence and Causes of Visual Loss Among HIV-Infected Individuals With Visual Loss in Uganda.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  119. MARSHALL BD , Shannon K, Kerr T, Zhang R, et al
    Survival Sex Work and Increased HIV Risk Among Sexual Minority Street-Involved Youth.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  120. TAIWO BO , Idoko JA, Welty LJ, Otoh I, et al
    Assessing the Viorologic and Adherence Benefits of Patient-Selected HIV Treatment Partners in a Resource-limited Setting.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  121. PATTANAPANYASAT K , Noulsri E, Lerdwana S, Sukapirom K, et al
    The Use of Glutaraldehyde-Fixed Chicken Red Blood Cells as Counting Beads for Performing Affordable Single-Platform CD4+ T-Lymphocyte Count in HIV-1-Infected Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  122. NABATIYAN A , Baumann MA, Parpia Z, Kelso D, et al
    A Lateral Flow-Based Ultra-Sensitive p24 HIV Assay Utilizing Fluorescent Microparticles.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  123. DECKER MR , Miller E, Raj A, Saggurti N, et al
    Indian Men's Use of Commercial Sex Workers: Prevalence, Condom Use, and Related Gender Attitudes.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  124. VAN GRIENSVEN F , Varangrat A, Wimonsate W, Tanpradech S, et al
    Trends in HIV Prevalence, Estimated HIV Incidence, and Risk Behavior Among Men Who Have Sex With Men in Bangkok, Thailand, 2003-2007.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  125. VAN VONDEREN MG , Blumer RM, Hassink EA, Sutinen J, et al
    Insulin Sensitivity in Multiple Pathways is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  126. YIN MT , Lu D, Cremers S, Tien PC, et al
    Short-Term Bone Loss in HIV-Infected Premenopausal Women.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  127. SAITOH A , Capparelli E, Aweeka F, Sarles E, et al
    CYP2C19 Genetic Variants Affect Nelfinavir Pharmacokinetics and Virologic Response in HIV-1-Infected Children Receiving Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  128. BREILH D , Djabarouti S, Trimoulet P, Le Bail B, et al
    Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.
    J Acquir Immune Defic Syndr. 2009;52:428-30.
    PubMed     Text format     Related articles   


  129. FUMAZ CR , Gonzalez-Garcia M, Borras X, Ferrer MJ, et al
    Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress.
    J Acquir Immune Defic Syndr. 2009;52:427-8.
    PubMed     Text format     Related articles   


  130. ATUN R , Kazatchkine M
    Promoting country ownership and stewardship of health programs: The global fund experience.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S67-8.
    PubMed     Text format     Related articles    Abstract available


  131. HARRINGTON M
    Community involvement in HIV and tuberculosis research.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S63-6.
    PubMed     Text format     Related articles    Abstract available


  132. RABKIN M , El-Sadr WM, De Cock KM
    The impact of HIV scale-up on health systems: A priority research agenda.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S6-11.
    PubMed     Text format     Related articles    Abstract available


  133. NASH D , Elul B, Rabkin M, Tun M, et al
    Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengthening.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S58-62.
    PubMed     Text format     Related articles    Abstract available


  134. BRAITSTEIN P , Einterz RM, Sidle JE, Kimaiyo S, et al
    "Talkin' about a revolution": How electronic health records can facilitate the scale-up of HIV care and treatment and catalyze primary care in resource-constrained settings.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S54-7.
    PubMed     Text format     Related articles    Abstract available


  135. MYER L , Akugizibwe P
    Impact of HIV treatment scale-up on women's reproductive health care and reproductive rights in Southern Africa.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S52-3.
    PubMed     Text format     Related articles    Abstract available


  136. PARKER RG
    Civil society, political mobilization, and the impact of HIV scale-up on health systems in Brazil.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S49-51.
    PubMed     Text format     Related articles    Abstract available


  137. SHIFFMAN J , Berlan D, Hafner T
    Has aid for AIDS raised all health funding boats?
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S45-8.
    PubMed     Text format     Related articles    Abstract available


  138. LIEBERMAN S , Gottret P, Yeh E, de Beyer J, et al
    International health financing and the response to AIDS.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S38-44.
    PubMed     Text format     Related articles    Abstract available


  139. EMBREY M , Hoos D, Quick J
    How AIDS funding strengthens health systems: progress in pharmaceutical management.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S34-7.
    PubMed     Text format     Related articles    Abstract available


  140. JUSTMAN JE , Koblavi-Deme S, Tanuri A, Goldberg A, et al
    Developing laboratory systems and infrastructure for HIV scale-up: A tool for health systems strengthening in resource-limited settings.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S30-3.
    PubMed     Text format     Related articles    Abstract available


  141. LEVINE R , Oomman N
    Global HIV/AIDS funding and health systems: Searching for the win-win.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S3-5.
    PubMed     Text format     Related articles    Abstract available


  142. DOHRN J , Nzama B, Murrman M
    The impact of HIV scale-up on the role of nurses in South Africa: Time for a new approach.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S27-9.
    PubMed     Text format     Related articles    Abstract available


  143. ABRAMS EJ , El-Sadr WM
    Lessons from Harlem: Relevance to a global epidemic.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S24-6.
    PubMed     Text format     Related articles    Abstract available


  144. SHERR K , Pfeiffer J, Mussa A, Vio F, et al
    The role of nonphysician clinicians in the rapid expansion of HIV care in Mozambique.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S20-3.
    PubMed     Text format     Related articles    Abstract available


  145. KAMARULZAMAN A
    Impact of HIV prevention programs on drug users in Malaysia.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S17-9.
    PubMed     Text format     Related articles    Abstract available



  146. HIV scale-up and global health systems. Proceedings of a meeting. September 2008. Bellagio, Italy.
    J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S1-68.
    PubMed     Text format     Related articles   


    October 2009
  147. WANG R , Lagakos SW
    On the Use of Adjusted Cross-Sectional Estimators of HIV Incidence.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  148. CHEN JY , Ogwu AC, Svab P, Lockman S, et al
    Antiretroviral Treatment Initiation Among HIV-Infected Pregnant Women with Low CD4+ Cell Counts in Gaborone, Botswana.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  149. SHAFFER DN , Ngetich IK, Bautista CT, Sawe FK, et al
    HIV-1 Incidence Rates and Risk Factors in Agricultural Workers and Dependents in Rural Kenya: 36-Month Follow-Up of the Kericho HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  150. BOULDOUYRE MA , Charreau I, Marchou B, Tangre P, et al
    Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  151. KAFULAFULA G , Hoover DR, Taha TE, Thigpen M, et al
    Frequency of Gastroenteritis and Gastroenteritis-Associated Mortality with Early Weaning in HIV-1-Uninfected Children Born to HIV-Infected Women in Malawi.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  152. SCHERRER AU , von Wyl V, Fux CA, Opravil M, et al
    Implementation of Raltegravir in Routine Clinical Practice: Selection Criteria for Choosing This Drug, Virologic Response Rates, and Characteristics of Failures.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  153. YEHIA BR , Fleishman JA, Hicks PL, Ridore M, et al
    Inpatient Health Services Utilization Among HIV-Infected Adult Patients in Care 2002-2007.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  154. VAN TIENEN C , van der Loeff MS, Zaman SM, Vincent T, et al
    Two Distinct Epidemics: The Rise of HIV-1 and Decline of HIV-2 Infection Between 1990 and 2007 in Rural Guinea-Bissau.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  155. BUCHACZ K , Baker RK, Young B, Brooks JT, et al
    Changes in the Use of HIV Antiretroviral Resistance Testing in a Large Cohort of U.S. Patients, 1999 to 2006.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  156. FATKENHEUER G , Hoffmann C, Slim J, Rouzier R, et al
    Short-Term Administration of the CCR5 Antagonist Vicriviroc to Patients With HIV and HCV Coinfection is Safe and Tolerable.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  157. REID SE , Dai JY, Wang J, Sichalwe BN, et al
    Pregnancy, Contraceptive Use, and HIV Acquisition in HPTN 039: Relevance for HIV Prevention Trials Among African Women.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  158. FOX MP , Ive P, Long L, Maskew M, et al
    High Rates of Survival, Immune Reconstitution and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  159. HORBERG M , Tang B, Towner W, Silverberg M, et al
    Impact of Tenofovir on Renal Function in HIV-Infected Antiretroviral Naive Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  160. KHEIRANDISH P , Seyedalinaghi SA, Hosseini M, Jahani MR, et al
    Prevalence and Correlates of HIV Infection Among Male Injection Drug Users in Detention, Tehran, Iran.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  161. OPRAVIL M , Klimkait T, Louvel S, Wolf E, et al
    Prior Therapy Influences the Efficacy of Lamivudine Monotherapy in Patients with Lamivudine-resistant HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  162. CAMPSMITH ML , Rhodes PH, Hall HI, Green TA, et al
    Undiagnosed HIV Prevalence Among Adults and Adolescents in the United States at the End of 2006.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  163. BOUSHERI S , Burke C, Ssewanyana I, Harrigan R, et al
    Infection With Different HIV Subtypes Is Associated With CD4 Activation-Associated Dysfunction and Apoptosis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  164. LETANG E , Almeida JM, Miro JM, Ayala E, et al
    Predictors of Immune Reconstitution Inflammatory Syndrome-Associated With Kaposi Sarcoma in Mozambique: A Prospective Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  165. WALLIS C , Sanne I, Venter F, Mellors J, et al
    Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  166. CREEK TL , Kim A, Lu L, Bowen A, et al
    Hospitalization and Mortality Among Primarily Non-breastfed Children During a Large Outbreak of Diarrhea and Malnutrition in Botswana, 2006.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  167. ROSSI R , Nuzzo A, Guaraldi G, Orlando G, et al
    The role of the Framingham risk score to predict the presence of subclinical coronary atherosclerosis in patients with HIV infection.
    J Acquir Immune Defic Syndr. 2009;52:303-4.
    PubMed     Text format     Related articles   


  168. GOICOECHEA M , Smith D, May S, Mathews C, et al
    Prevalence and T-cell phenotype of slow HIV disease progressors with robust HIV replication.
    J Acquir Immune Defic Syndr. 2009;52:299-301.
    PubMed     Text format     Related articles   


    September 2009
  169. WILLIG JH , Echevarria J, Westfall AO, Iglesias D, et al
    Durability of Initial Antiretroviral Therapy in a Resource Constrained Setting and the Potential Need for Zidovudine Weight-Based Dosing.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  170. HOMSY J , Moore D, Barasa A, Were W, et al
    Breastfeeding, Mother-to-Child HIV Transmission, and Mortality Among Infants Born to HIV-Infected Women on Highly Active Antiretroviral Therapy in Rural Uganda.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  171. AVIDAN NU , Goldstein D, Rozenberg L, McLaughlin M, et al
    Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  172. AUVERT B , Lissouba P, Cutler E, Zarca K, et al
    Association of Oncogenic and Nononcogenic Human Papillomavirus With HIV Incidence.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  173. GARRABOU G , Moren C Phd Student, Gallego-Escuredo JM Phd Student, Milinkovic A, et al
    Genetic and Functional Mitochondrial Assessment of HIV-Infected Patients Developing HAART-Related Hyperlactatemia.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  174. ONYANGO-MAKUMBI C , Bagenda D, Mwatha A, Omer SB, et al
    Early Weaning of HIV-Exposed Uninfected Infants and Risk of Serious Gastroenteritis: Findings from Two Perinatal HIV Prevention Trials in Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  175. VAGENAS P , Williams VG, Piatak M Jr, Bess JW Jr, et al
    Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  176. SQUILLACE N , Zona S, Stentarelli C, Orlando G, et al
    Detectable HIV Viral Load Is Associated With Metabolic Syndrome.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  177. SINGH JC , Kuohung V, Palefsky JM
    Efficacy of Trichloroacetic Acid in the Treatment of Anal Intraepithelial Neoplasia in HIV-Positive and HIV-Negative Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  178. SHIELS MS , Cole SR, Kirk GD, Poole C, et al
    A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  179. VESSIERE A , Rousset D, Kfutwah A, Leoz M, et al
    Diagnosis and Monitoring of HIV-1 Group O-Infected Patients in Cameroun.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  180. MAY S , Gamst A, Haubrich R, Benson C, et al
    Pooled Nucleic Acid Testing to Identify Antiretroviral Treatment Failure During HIV Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  181. MAGNUS M , Jones K, Phillips G, Binson D, et al
    Characteristics Associated With Retention Among African American and Latino Adolescent HIV-Positive Men: Results From the Outreach, Care, and Prevention to Engage HIV-Seropositive Young MSM of Color Special Project of National Significance Initiative.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  182. WEINTROB AC , Grandits GA, Agan BK, Ganesan A, et al
    Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  183. HAISSMAN JM , Vestergaard LS, Sembuche S, Erikstrup C, et al
    Plasma Cytokine Levels in Tanzanian HIV-1-Infected Adults and the Effect of Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  184. LEWDEN C , Thiebaut R, Boufassa F, Coulibaly A, et al
    Comparison of Early CD4 T-Cell Count in HIV-1 Seroconverters in Cote d'Ivoire and France: The ANRS PRIMO-CI and SEROCO Cohorts.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  185. GENG EH , Bangsberg DR, Musinguzi N, Emenyonu N, et al
    Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  186. BRAITSTEIN P , Ayuo P, Mwangi A, Wools-Kaloustian K, et al
    Sustainability of First-Line Antiretroviral Regimens: Findings From a Large HIV Treatment Program in Western Kenya.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  187. DORJGOCHOO T , Noel F, Deschamps MM, Theodore H, et al
    Risk Factors for HIV Infection Among Haitian Adolescents and Young Adults Seeking Counseling and Testing in Port-au-Prince.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  188. SPRADLING PR , Richardson JT, Buchacz K, Moorman AC, et al
    Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996-2007.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  189. COCKERHAM L , Scherzer R, Zolopa A, Rimland D, et al
    Association of HIV Infection, Demographic and Cardiovascular Risk Factors With All-Cause Mortality in the Recent HAART Era.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  190. STOCKMAN JK , Campbell JC, Celentano DD
    Sexual Violence and HIV Risk Behaviors Among a Nationally Representative Sample of Heterosexual American Women: The Importance of Sexual Coercion.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  191. JIN F , Prestage GP, Imrie J, Kippax SC, et al
    Anal Sexually Transmitted Infections and Risk of HIV Infection in Homosexual Men.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  192. MARKS KM , Clarke RM, Bussel JB, Talal AH, et al
    Risk Factors for Thrombocytopenia in HIV-Infected Persons in the Era of Potent Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  193. VARGHESE V , Shahriar R, Rhee SY, Liu T, et al
    Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  194. JIN X , Smith K, Chen RY, Ding G, et al
    HIV Prevalence and Risk Behaviors Among Male Clients of Female Sex Workers in Yunnan, China.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  195. HARRISON KM , Song R, Zhang X
    Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  196. KLEIN DB , Hurley LB, Horberg MA, Silverberg MJ, et al
    Increased Rates of Appendicitis in HIV-Infected Men: 1991-2005.
    J Acquir Immune Defic Syndr. 2009;52:139-40.
    PubMed     Text format     Related articles   


  197. JINNOPAT P , Isarangkura-Na-Ayuthaya P, Utachee P, Kitagawa Y, et al
    Impact of Amino Acid Variations in Gag and Protease of Human Immunodeficiency Virus Type 1 CRF01_AE Strains on Drug Susceptibility of Virus to Protease Inhibitors.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  198. GURJAR SR , Mangaiarkarasi A, Ravi V, Ranga U, et al
    Molecular Characterization of a Full-Length Genome of a HIV-2 Isolate From India.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  199. MOFENSON LM
    Prevention of Breast Milk Transmission of HIV: The Time Is Now.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles   


  200. LAEYENDECKER O , Redd AD, Lutalo T, Gray RH, et al
    Frequency of Long-Term Nonprogressors in HIV-1 Seroconverters From Rakai Uganda.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  201. MATTEELLI A , Saleri N, Villani P, Bonkoungou V, et al
    Reversible reduction of nevirapine plasma concentrations during rifampicin treatment in patients coinfected with HIV-1 and tuberculosis.
    J Acquir Immune Defic Syndr. 2009;52:64-9.
    PubMed     Text format     Related articles    Abstract available


  202. BAKER JV , Duprez D, Rapkin J, Hullsiek KH, et al
    Untreated HIV infection and large and small artery elasticity.
    J Acquir Immune Defic Syndr. 2009;52:25-31.
    PubMed     Text format     Related articles    Abstract available


  203. TOZZI V , Balestra P, Salvatori MF, Vlassi C, et al
    Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2009;52:56-63.
    PubMed     Text format     Related articles    Abstract available


  204. VAN DER SNOEK EM , Amelink A, van der Ende ME, den Hollander JC, et al
    Photodynamic therapy with topical metatetrahydroxychlorin (Fosgel) is ineffective for the treatment of anal intraepithelial neoplasia, grade III.
    J Acquir Immune Defic Syndr. 2009;52:141-3.
    PubMed     Text format     Related articles   


  205. CHI BH , Giganti M, Mulenga PL, Limbada M, et al
    CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia.
    J Acquir Immune Defic Syndr. 2009;52:125-31.
    PubMed     Text format     Related articles    Abstract available


  206. SERRAINO D , Zucchetto A, Suligoi B, Bruzzone S, et al
    Survival after AIDS diagnosis in Italy, 1999-2006: a population-based study.
    J Acquir Immune Defic Syndr. 2009;52:99-105.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  207. SCHMALTZ CA , Sant'anna FM, Neves SC, Velasque LD, et al
    Influence of HIV Infection on Mortality in a Cohort of Patients Treated for Tuberculosis in the Context of Wide Access to HAART, in Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  208. KILEWO C , Karlsson K, Ngarina M, Massawe A, et al
    Prevention of Mother-to-Child Transmission of HIV-1 Through Breastfeeding by Treating Mothers With Triple Antiretroviral Therapy in Dar es Salaam, Tanzania: The Mitra Plus Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  209. VAN RIE A , Dow A, Mupuala A, Stewart P, et al
    Neurodevelopmental Trajectory of HIV-Infected Children Accessing Care in Kinshasa, Democratic Republic of Congo.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  210. RUAN Y , Jia Y, Zhang X, Liang H, et al
    Incidence of HIV-1, Syphilis, Hepatitis B, and Hepatitis C Virus Infections and Predictors Associated With Retention in a 12-Month Follow-Up Study Among Men Who Have Sex With Men in Beijing, China.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  211. MCQUILLAN GM , Kruszon-Moran D, Granade T, Feldman JW, et al
    Seroprevalence of Human Immunodeficiency Virus in the US Household Population Aged 18-49 Years: The National Health and Nutrition Examination Surveys, 1999-2006.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  212. SHAH M , Variava E, Holmes CB, Coppin A, et al
    Diagnostic Accuracy of a Urine Lipoarabinomannan Test for Tuberculosis in Hospitalized Patients in a High HIV Prevalence Setting.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  213. MARIE-EVE R , Petros I, Chutema P, Md RT, et al
    Screening and Treating Cervical Cancer in HIV-Positive Women in Cambodia.
    J Acquir Immune Defic Syndr. 2009;51:644-6.
    PubMed     Text format     Related articles   


  214. SHANKARKUMAR U , Pawar A, Prabu G, Ghosh K, et al
    Role of HLA Class I (HLA-A, B) and HLA Class II (HLA-DRB, DQB) in HIV-1 Patients With and Without Pulmonary Tuberculosis.
    J Acquir Immune Defic Syndr. 2009;51:640-1.
    PubMed     Text format     Related articles   


  215. SHORTER MM , Ostermann J, Crump JA, Tribble AC, et al
    Characteristics of HIV Voluntary Counseling and Testing Clients Before and During Care and Treatment Scale-Up in Moshi, Tanzania.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  216. WEISER SD , Fernandes KA, Brandson EK, Lima VD, et al
    The Association Between Food Insecurity and Mortality Among HIV-Infected Individuals on HAART.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  217. LEE GA , Schwarz JM, Patzek S, Kim S, et al
    The Acute Effects of HIV Protease Inhibitors on Insulin Suppression of Glucose Production in Healthy HIV-Negative Men.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  218. SITTA R , Lert F, Gueguen A, Spire B, et al
    No Variability Across Centers in Adherence and Response to HAART in French Hospitals: Results From the ANRS-EN12-VESPA Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  219. ELLIOTT-DESORBO DK , Martin S, Wolters PL
    Stressful Life Events and Their Relationship to Psychological and Medical Functioning in Children and Adolescents With HIV Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  220. ANDERSON JS , Hoy J, Hillman R, Barnden M, et al
    A Randomized, Placebo-Controlled, Dose-Escalation Study to Determine the Safety, Tolerability, and Immunogenicity of an HPV-16 Therapeutic Vaccine in HIV-Positive Participants With Oncogenic HPV Infection of the Anus.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  221. AISSANI B , Ogwaro KM, Shrestha S, Tang J, et al
    The Major Histocompatibility Complex Conserved Extended Haplotype 8.1 in AIDS-Related Non-Hodgkin Lymphoma.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  222. LOPARDO GD , Bissio E, Iannella MD, Crespo AD, et al
    Good Neurocognitive Performance Measured by the International HIV Dementia Scale in Early HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  223. IMAZ A , Del Saz SV, Ribas MA, Curran A, et al
    Raltegravir, Etravirine, and Ritonavir-Boosted Darunavir: A Safe and Successful Rescue Regimen for Multidrug-Resistant HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  224. KEMPF MC , Pisu M, Dumcheva A, Westfall AO, et al
    Gender Differences in Discontinuation of Antiretroviral Treatment Regimens.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  225. HSIEH YH , Rothman RE
    Reply to the Letter Regarding "Impact of HIV Status on Outcome of Infectious Complications in Intravenous Drug Users".
    J Acquir Immune Defic Syndr. 2009;51:507-8.
    PubMed     Text format     Related articles   


  226. RAMOS CG , Barcelos NT
    Does Episodic Antiretroviral Therapy Increase HIV Transmission Risk Compared With Continuous Therapy?
    J Acquir Immune Defic Syndr. 2009;51:506.
    PubMed     Text format     Related articles   


  227. MERTZ D , Viktorin N, Wolbers M, Fluckiger U, et al
    Impact of HIV Status on Outcome of Infectious Complications in Intravenous Drug Users.
    J Acquir Immune Defic Syndr. 2009;51:506-7.
    PubMed     Text format     Related articles   


  228. HAMERS RL , Beer ID, Kaura H, van Vugt M, et al
    Oral Fluid HIV Rapid Testing in Southern Africa Is Suitable for Population-Level Surveillance But May Not Be So for Individual Diagnosis (Invited Response to Scott et al: Can Oral Fluid Testing Be Used to Replace Blood-Based HIV Rapid Testing to Improve
    J Acquir Immune Defic Syndr. 2009;51:648-649.
    PubMed     Text format     Related articles   


  229. SCOTT LE , Noble LD, Langeveldt M, Jentsch U, et al
    Can Oral Fluid Testing Be Used to Replace Blood-Based HIV Rapid Testing to Improve Access to Diagnosis in South Africa?
    J Acquir Immune Defic Syndr. 2009;51:646-648.
    PubMed     Text format     Related articles   


  230. TINCATI C , Bellistri GM, Casana M, Merlini E, et al
    CD8+ Hyperactivation and Senescence Correlate With Early Carotid Intima-Media Thickness in HIV+ Patients With No Cardiovascular Disease.
    J Acquir Immune Defic Syndr. 2009;51:642-644.
    PubMed     Text format     Related articles   


  231. KRISHNA G , Moton A, Ma L, Martinho M, et al
    Effects of oral posaconazole on the pharmacokinetics of atazanavir alone and with ritonavir or with efavirenz in healthy adult volunteers.
    J Acquir Immune Defic Syndr. 2009;51:437-44.
    PubMed     Text format     Related articles    Abstract available


  232. NEL A , Smythe S, Young K, Malcolm K, et al
    Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women.
    J Acquir Immune Defic Syndr. 2009;51:416-23.
    PubMed     Text format     Related articles    Abstract available


  233. GEFFEN N
    Justice after AIDS denialism: should there be prosecutions and compensation?
    J Acquir Immune Defic Syndr. 2009;51:454-5.
    PubMed     Text format     Related articles   


    July 2009
  234. BUSSE KH , Hadigan C, Chairez C, Alfaro RM, et al
    Gemfibrozil Concentrations Are Significantly Decreased in the Presence of Lopinavir-Ritonavir.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  235. MARKOWITZ M , Nguyen BY, Gotuzzo E, Mendo F, et al
    Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  236. GRAHAM SM , Masese L, Gitau R, Mwakangalu D, et al
    Increased Risk of Genital Ulcer Disease in Women During the First Month After Initiating Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  237. MARGOT NA , Enejosa J, Cheng AK, Miller MD, et al
    Development of HIV-1 Drug Resistance Through 144 Weeks in Antiretroviral-Naive Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With Lamivudine/Zidovudine and Efavirenz in Study GS-01-934.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  238. HAWKINS CA , Chaplin B, Idoko J, Ekong E, et al
    Clinical and Genotypic Findings in HIV-Infected Patients With the K65R Mutation Failing First-Line Antiretroviral Therapy in Nigeria.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  239. OCHIENG W , Sauermann U, Schulte R, Suh YS, et al
    Susceptibility to Simian Immunodeficiency Virus Ex Vivo Predicts Outcome of a Prime-Boost Vaccine After SIVmac239 Challenge.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  240. MBIDA AD , Sosso S, Flori P, Saoudin H, et al
    Measure of Viral Load by Using the Abbott Real-Time HIV-1 Assay on Dried Blood and Plasma Spot Specimens Collected in 2 Rural Dispensaries in Cameroon.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  241. BOFFITO M , Jackson A, Lamorde M, Back D, et al
    Pharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  242. MMIRO FA , Aizire J, Mwatha AK, Eshleman SH, et al
    Predictors of Early and Late Mother-to-Child Transmission of HIV in a Breastfeeding Population: HIV Network for Prevention Trials 012 Experience, Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  243. WEINBERG A , Huang S, Fenton T, Patterson-Bartlett J, et al
    Virologic and Immunologic Correlates With the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on Highly Active Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  244. LOWRANCE DW , Ndamage F, Kayirangwa E, Ndagije F, et al
    Adult Clinical and Immunologic Outcomes of the National Antiretroviral Treatment Program in Rwanda During 2004-2005.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  245. BEDIMO RJ , McGinnis KA, Dunlap M, Rodriguez-Barradas MC, et al
    Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  246. GREENGRASS V , Lohman B, Morris L, Plate M, et al
    Assessment of the Low-Cost Cavidi ExaVir Load Assay for Monitoring HIV Viral Load in Pediatric and Adult Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  247. ANDERSON JS , Walker J, Nolta JA, Bauer G, et al
    Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  248. VAN LUIN M , Gras L, Richter C, Ende ME, et al
    Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  249. MORSICA G , Bagaglio S, Cicconi P, Capobianchi MR, et al
    Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  250. BARSS P , Grivna M, Ganczak M, Bernsen R, et al
    Effects of a Rapid Peer-based HIV/AIDS Educational Intervention on Knowledge and Attitudes of High School Students in a High-Income Arab Country.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  251. WHITE DA , Scribner AN, Huang JV
    A Comparison of Patient Acceptance of Fingerstick Whole Blood and Oral Fluid Rapid HIV Screening in an Emergency Department.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  252. VALENTE TW , Zogg JB, Christensen S, Richardson J, et al
    Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  253. LI H , Chen X, Jin X, Liu Z, et al
    Proliferation, But Not Interleukin 2 Production, of Gag-Specific CD8+ T Cells Is Associated With Low HIV Viremia and High CD4 Counts in HIV-1-Infected Chinese Individuals.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  254. SMIT E , Bhattacharya S, Osman H, Taylor S, et al
    Increased Frequency of HIV-1 Viral Load Blip Rate Observed After Switching From Roche Cobas Amplicor to Cobas Taqman Assay.
    J Acquir Immune Defic Syndr. 2009;51:364-5.
    PubMed     Text format     Related articles   


  255. GUST DA , Wiegand RE, Para M, Chen RT, et al
    HIV Testing Outside of the Study Among Men Who Have Sex With Men Participating in an HIV Vaccine Efficacy Trial.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  256. COSTANTINI A , Giuliodoro S, Butini L, Silvestri G, et al
    Abnormalities of Erythropoiesis During HIV-1 Disease: A Longitudinal Analysis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  257. WILSON DP
    Modelling based on Australian HIV notifications data suggests homosexual age mixing is primarily assortative.
    J Acquir Immune Defic Syndr. 2009;51:356-60.
    PubMed     Text format     Related articles    Abstract available


  258. BARTOLO I , Casanovas J, Bastos R, Rocha C, et al
    HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique.
    J Acquir Immune Defic Syndr. 2009;51:323-31.
    PubMed     Text format     Related articles    Abstract available


  259. APRIL MD , Walensky RP, Chang Y, Pitt J, et al
    HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies.
    J Acquir Immune Defic Syndr. 2009;51:310-6.
    PubMed     Text format     Related articles    Abstract available


  260. LEBRECHT D , Venhoff AC, Kirschner J, Wiech T, et al
    Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.
    J Acquir Immune Defic Syndr. 2009;51:258-63.
    PubMed     Text format     Related articles    Abstract available


  261. TALBOT A , Machouf N, Thomas R, Marcotte S, et al
    Switch From Enfuvirtide to Raltegravir in Patients With Undetectable Viral Load: Efficacy and Safety at 24 Weeks in a Montreal Cohort.
    J Acquir Immune Defic Syndr. 2009;51:362-364.
    PubMed     Text format     Related articles   


  262. AIRO P , Scarsi M, Malagoli A, Carella G, et al
    The Convenience of Flow Cytometry for HLA-B*5701 Screening to Prevent Abacavir Hypersensitivity Reactions.
    J Acquir Immune Defic Syndr. 2009;51:361-2.
    PubMed     Text format     Related articles   


  263. EHRHARDT AA , Sawires S, McGovern T, Peacock D, et al
    Gender, empowerment, and health: what is it? How does it work?
    J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S96-S105.
    PubMed     Text format     Related articles    Abstract available


  264. SHAWKY S , Soliman C, Kassak KM, Oraby D, et al
    HIV surveillance and epidemic profile in the Middle East and North Africa.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S83-95.
    PubMed     Text format     Related articles    Abstract available


  265. SAWIRES S , Birnbaum N, Abu-Raddad L, Szekeres G, et al
    Twenty-five years of HIV: lessons for low prevalence scenarios.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S75-82.
    PubMed     Text format     Related articles    Abstract available


  266. SHAWKY S , Soliman C, Sawires S
    Gender and HIV in the Middle East and North Africa: lessons for low prevalence scenarios.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S73-4.
    PubMed     Text format     Related articles   


  267. PEACOCK D , Stemple L, Sawires S, Coates TJ, et al
    Men, HIV/AIDS, and human rights.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S119-25.
    PubMed     Text format     Related articles    Abstract available


  268. DWORKIN SL , Kambou SD, Sutherland C, Moalla K, et al
    Gendered empowerment and HIV prevention: policy and programmatic pathways to success in the MENA region.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S111-8.
    PubMed     Text format     Related articles    Abstract available


  269. REMIEN RH , Chowdhury J, Mokhbat JE, Soliman C, et al
    Gender and care: access to HIV testing, care, and treatment.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 3:S106-10.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  270. MEGAZZINI KM , Chintu N, Vermund SH, Redden DT, et al
    Predictors of Rapid HIV Testing Acceptance and Successful Nevirapine Administration in Zambian Labor Wards.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  271. MOORE ZS , McCoy S, Kuruc J, Hilton M, et al
    Number of Named Partners and Number of Partners Newly Diagnosed With HIV Infection Identified by Persons With Acute Versus Established HIV Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  272. FISHER M , Moyle GJ, Shahmanesh M, Orkin C, et al
    A Randomized Comparative Trial of Continued Zidovudine/Lamivudine or Replacement With Tenofovir Disoproxil Fumarate/Emtricitabine in Efavirenz-Treated HIV-1-Infected Individuals.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  273. LINAS BP , Losina E, Rockwell A, Walensky RP, et al
    Improving Outcomes in State AIDS Drug Assistance Programs.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  274. BANSI L , Turner J, Gilson R, Post F, et al
    Is 1 Alanine Transaminase >200 IU Enough to Define an Alanine Transaminase Flare in HIV-Infected Populations? A New Definition Derived From a Large Cohort Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  275. NDIAYE HD , Kane CT, Vidal N, Niama FR, et al
    Surprisingly High Prevalence of Subtype C and Specific HIV-1 Subtype/CRF Distribution in Men Having Sex With Men in Senegal.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  276. NUTTBROCK L , Hwahng S, Bockting W, Rosenblum A, et al
    Lifetime Risk Factors for HIV/Sexually Transmitted Infections Among Male-to-Female Transgender Persons.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  277. MICEK MA , Gimbel-Sherr K, Baptista AJ, Matediana E, et al
    Loss to Follow-Up of Adults in Public HIV Care Systems in Central Mozambique: Identifying Obstacles to Treatment.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  278. LYNEN L , An S, Koole O, Thai S, et al
    An Algorithm to Optimize Viral Load Testing in HIV-Positive Patients With Suspected First-Line Antiretroviral Therapy Failure in Cambodia.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  279. KUATE S , Mikolajczyk RT, Forgwei GW, Tih PM, et al
    Time Trends and Regional Differences in the Prevalence of HIV Infection Among Women Attending Antenatal Clinics in 2 Provinces in Cameroon.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  280. DUMOND JB , Patterson KB, Pecha AL, Werner RE, et al
    Maraviroc Concentrates in the Cervicovaginal Fluid and Vaginal Tissue of HIV-Negative Women.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  281. SHAHMANESH M , Wayal S, Copas A, Patel V, et al
    A Study Comparing Sexually Transmitted Infections and HIV Among Ex-Red-Light District and Non-Red-Light District Sex Workers After the Demolition of Baina Red-Light District.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  282. NOVITSKY V , Wang R, Kebaabetswe L, Greenwald J, et al
    Better Control of Early Viral Replication Is Associated With Slower Rate of Elicited Antiviral Antibodies in the Detuned Enzyme Immunoassay During Primary HIV-1C Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  283. AMMANN AJ
    Optimal Versus Suboptimal Treatment for HIV-Infected Pregnant Women and HIV-Exposed Infants in Clinical Research Studies.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles   


  284. CHEN JH , Wong KH, Li P, Chan KC, et al
    Molecular Epidemiological Study of HIV-1 CRF01_AE Transmission in Hong Kong.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  285. ROBINSON-PAPP J , Gonzalez-Duarte A, Simpson DM, Rivera-Mindt M, et al
    The Roles of Ethnicity and Antiretrovirals in HIV-Associated Polyneuropathy: A Pilot Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  286. POTARD V , Weiss L, Lamontagne F, Rouveix E, et al
    Trends in Post-Infection CD4 Cell Counts and Plasma HIV-1 RNA Levels in HIV-1-Infected Patients in France Between 1997 and 2005.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  287. KIGOZI IM , Dobkin LM, Martin JN, Geng EH, et al
    Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  288. DOMINGO P , Suarez-Lozano I, Torres F, Pomar V, et al
    Bacterial Meningitis in HIV-1-Infected Patients in the Era of Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  289. MACLACHLAN E , Mayer KH, Barnabas R, Sanchez J, et al
    The Potential Role of Biomarkers in HIV Preventive Vaccine Trials: A Critical Review.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  290. BROWN TT , McComsey GA, King MS, Qaqish RB, et al
    Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  291. DOHERTY IA , Schoenbach VJ, Adimora AA
    Sexual Mixing Patterns and Heterosexual HIV Transmission Among African Americans in the Southeastern United States.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  292. ESHLEMAN SH , Khaki L, Laeyendecker O, Piwowar-Manning E, et al
    Detection of Individuals With Acute HIV-1 Infection Using the ARCHITECT HIV Ag/Ab Combo Assay.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  293. KUHN L , Semrau K, Ramachandran S, Sinkala M, et al
    Mortality and Virologic Outcomes After Access to Antiretroviral Therapy Among a Cohort of HIV-Infected Women Who Received Single-Dose Nevirapine in Lusaka, Zambia.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  294. GERMAN P , Parikh S, Lawrence J, Dorsey G, et al
    Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  295. LEHMAN DA , Chung MH, Mabuka JM, John-Stewart GC, et al
    Lower Risk of Resistance After Short-Course HAART Compared With Zidovudine/Single-Dose Nevirapine Used for Prevention of HIV-1 Mother-to-Child Transmission.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  296. MORA S , Vigano A, Cafarelli L, Pattarino G, et al
    Applicability of Quantitative Ultrasonography of the Radius and Tibia in HIV-Infected Children and Adolescents.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  297. MABUKA JM , Mackelprang RD, Lohman-Payne B, Majiwa M, et al
    CCR2-64I Polymorphism Is Associated With Lower Maternal HIV-1 Viral Load and Reduced Vertical HIV-1 Transmission.
    J Acquir Immune Defic Syndr. 2009;51:235-237.
    PubMed     Text format     Related articles   


  298. VAN GEERTRUYDEN JP , Colebunders R, D'alessandro U
    HIV-1-Infected Individuals Traveling to Malaria Endemic Areas.
    J Acquir Immune Defic Syndr. 2009;51:234-235.
    PubMed     Text format     Related articles   


  299. WATTS DH , Huang S, Cohn SE, Smith L, et al
    Repeat Pregnancies Among HIV-Infected Women Enrolled in Clinical Trial PACTG1022.
    J Acquir Immune Defic Syndr. 2009;51:231-233.
    PubMed     Text format     Related articles   


  300. OBIMBO EM , Wamalwa D, Richardson B, Mbori-Ngacha D, et al
    Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality.
    J Acquir Immune Defic Syndr. 2009;51:209-15.
    PubMed     Text format     Related articles    Abstract available


  301. SOBIESZCYK ME , Xu G, Goodman K, Lucy D, et al
    Engaging members of African American and Latino communities in preventive HIV vaccine trials.
    J Acquir Immune Defic Syndr. 2009;51:194-201.
    PubMed     Text format     Related articles    Abstract available


  302. KANKASA C , Carter RJ, Briggs N, Bulterys M, et al
    Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility.
    J Acquir Immune Defic Syndr. 2009;51:202-8.
    PubMed     Text format     Related articles    Abstract available


  303. BASSETT IV , Wang B, Chetty S, Mazibuko M, et al
    Loss to care and death before antiretroviral therapy in Durban, South Africa.
    J Acquir Immune Defic Syndr. 2009;51:135-9.
    PubMed     Text format     Related articles    Abstract available


  304. PALMISANO L , Galluzzo CM, Giuliano M
    The importance of testing genotypic resistance in proviral DNA of patients fully responding to highly active antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2009;51:233-4.
    PubMed     Text format     Related articles   


    May 2009
  305. ELLER MA , Eller LA, Ouma BJ, Thelian D, et al
    Elevated Natural Killer Cell Activity Despite Altered Functional and Phenotypic Profile in Ugandans With HIV-1 Clade A or Clade D Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  306. FRENCH AL , Gawel SH, Hershow R, Benning L, et al
    Trends in Mortality and Causes of Death Among Women With HIV in the United States: A 10-Year Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  307. PINEDA JA , Recio E, Camacho A, Macias J, et al
    Liver Stiffness as a Predictor of Esophageal Varices Requiring Therapy in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  308. TOWNER W , Klein D, Kerrigan HL, Follansbee S, et al
    Virologic Outcomes of Changing Enfuvirtide to Raltegravir in HIV-1 Patients Well Controlled on an Enfuvirtide Based Regimen: 24-Week Results of the CHEER Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  309. UY J , Armon C, Buchacz K, Wood K, et al
    Initiation of HAART at Higher CD4 Cell Counts Is Associated With a Lower Frequency of Antiretroviral Drug Resistance Mutations at Virologic Failure.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  310. OSTER AM , Sullivan PS, Blair JM
    Prevalence of Cervical Cancer Screening of HIV-Infected Women in the United States.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  311. FERRY T , Raffi F, Collin-Filleul F, Dupon M, et al
    Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  312. ALCANTARA S , Reece J, Amarasena T, Rose RD, et al
    Thrombocytopenia Is Strongly Associated With Simian AIDS in Pigtail Macaques.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  313. ALONSO-ARIAS R , Lopez-Vazquez A, Diaz-Pena R, Sampere A, et al
    CD8dim and NKG2D Expression Defines Related Subsets of CD4+ T cells in HIV-Infected Patients With Worse Prognostic Factors.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  314. KHAN MR , Bolyard M, Sandoval M, Mateu-Gelabert P, et al
    Social and Behavioral Correlates of Sexually Transmitted Infection- and HIV-Discordant Sexual Partnerships in Bushwick, Brooklyn, New York.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  315. FENG L , Ding X, Lu R, Liu J, et al
    High HIV Prevalence Detected in 2006 and 2007 Among Men Who Have Sex With Men in China's Largest Municipality: An Alarming Epidemic in Chongqing, China.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  316. BENDAVID E , Wood R, Katzenstein DA, Bayoumi AM, et al
    Expanding Antiretroviral Options in Resource-Limited Settings-A Cost-Effectiveness Analysis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  317. JOHNSON BT , Scott-Sheldon LA, Smoak ND, Lacroix JM, et al
    Behavioral Interventions for African Americans to Reduce Sexual Risk of HIV: A Meta-Analysis of Randomized Controlled Trials.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  318. HANNA DB , Tsoi BW, Begier EM
    Most Positive HIV Western Blot Tests Do Not Diagnose New Cases in New York City: Implications for HIV Testing Programs.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  319. PACHECO AG , Tuboi SH, May SB, Moreira LF, et al
    Temporal Changes in Causes of Death Among HIV-Infected Patients in the HAART Era in Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  320. ANIS AH , Nosyk B, Sun H, Guh DP, et al
    Quality of Life of Patients With Advanced HIV/AIDS: Measuring the Impact of Both AIDS-Defining Events and Non-AIDS Serious Adverse Events.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  321. KITTIKRAISAK W , van Griensven F, Martin M, McNicholl J, et al
    Blood and Seminal Plasma HIV-1 RNA Levels Among HIV-1-Infected Injecting Drug Users Participating in the AIDSVAX B/E Efficacy Trial in Bangkok, Thailand.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  322. TUBOI SH , Schechter M, McGowan CC, Cesar C, et al
    Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  323. MICOL R , Buchy P, Guerrier G, Duong V, et al
    Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007).
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  324. DECKER MR , Seage GR 3rd, Hemenway D, Raj A, et al
    Intimate Partner Violence Functions as Both a Risk Marker and Risk Factor for Women's HIV Infection: Findings From Indian Husband-Wife Dyads.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  325. CHANTRY CJ , Israel-Ballard K, Moldoveanu Z, Peerson J, et al
    Effect of Flash-Heat Treatment on Immunoglobulins in Breast Milk.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  326. BRUYN G , Martinson NA, Nkala BD, Tshabangu N, et al
    Uptake of Male Circumcision in an HIV Vaccine Efficacy Trial.
    J Acquir Immune Defic Syndr. 2009;51:108-10.
    PubMed     Text format     Related articles   


  327. MORSICA G , Bagaglio S, Uberti-Foppa C, Galli L, et al
    Detection of Hepatitis C Mutants With Natural Resistance to NS3/4A Protease Inhibitors in HIV/HCV-Coinfected Individuals Treated With Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009;51:106-8.
    PubMed     Text format     Related articles   


  328. BLOM-POTAR MC , Bugault F, Lambotte O, Delfraissy JF, et al
    Soluble IL-7Ralpha (sCD127) and Measurement of IL-7 in the Plasma of HIV Patients.
    J Acquir Immune Defic Syndr. 2009;51:104-5.
    PubMed     Text format     Related articles   


  329. SOULIE C , Tubiana R, Simon A, Lambert-Niclot S, et al
    Presence of HIV-1 R5 Viruses in Cerebrospinal Fluid Even in Patients Harboring R5X4/X4 Viruses in Plasma.
    J Acquir Immune Defic Syndr. 2009;51:60-64.
    PubMed     Text format     Related articles    Abstract available


  330. MALLOLAS J , Podzamczer D, Milinkovic A, Domingo P, et al
    Efficacy and Safety of Switching From Boosted Lopinavir to Boosted Atazanavir in Patients With Virological Suppression Receiving a LPV/r-Containing HAART: The ATAZIP Study.
    J Acquir Immune Defic Syndr. 2009;51:29-36.
    PubMed     Text format     Related articles    Abstract available


  331. RICCI E , Malacrida S, Zanchetta M, Montagna M, et al
    Role of beta-Defensin-1 Polymorphisms in Mother-to-Child Transmission of HIV-1.
    J Acquir Immune Defic Syndr. 2009;51:13-19.
    PubMed     Text format     Related articles    Abstract available


  332. ALONSO M , Mazin R, Md RM, Cruz JR, et al
    Preventing transfusion-transmitted HIV infection in Latin America and the Caribbean: issues associated with blood donor interviews and sex between men.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S67-72.
    PubMed     Text format     Related articles    Abstract available


  333. CACERES CF , Mendoza W
    The national response to the HIV/AIDS epidemic in Peru: accomplishments and gaps--a review.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S60-6.
    PubMed     Text format     Related articles    Abstract available


  334. HALPERIN DT , de Moya EA, Perez-Then E, Pappas G, et al
    Understanding the HIV epidemic in the Dominican Republic: a prevention success story in the Caribbean?
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S52-9.
    PubMed     Text format     Related articles    Abstract available


  335. SANCHEZ J , Lama JR, Peinado J, Paredes A, et al
    High HIV and ulcerative sexually transmitted infection incidence estimates among men who have sex with men in Peru: awaiting for an effective preventive intervention.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S47-51.
    PubMed     Text format     Related articles    Abstract available


  336. STRATHDEE SA , Mausbach B, Lozada R, Staines-Orozco H, et al
    Predictors of sexual risk reduction among Mexican female sex workers enrolled in a behavioral intervention study.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S42-6.
    PubMed     Text format     Related articles    Abstract available


  337. SABIDO M , Giardina F, Hernandez G, Fernandez VH, et al
    The UALE Project: decline in the incidence of HIV and sexually transmitted infections and increase in the use of condoms among sex workers in Guatemala.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S35-41.
    PubMed     Text format     Related articles    Abstract available


  338. PAZ-BAILEY G , Morales-Miranda S, Jacobson JO, Gupta SK, et al
    High rates of STD and sexual risk behaviors among Garifunas in Honduras.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S26-34.
    PubMed     Text format     Related articles    Abstract available


  339. MAGIS-RODRIGUEZ C , Lemp G, Hernandez MT, Sanchez MA, et al
    Going North: Mexican migrants and their vulnerability to HIV.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S21-5.
    PubMed     Text format     Related articles    Abstract available


  340. HALL HI , Geduld J, Boulos D, Rhodes P, et al
    Epidemiology of HIV in the United States and Canada: current status and ongoing challenges.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S13-20.
    PubMed     Text format     Related articles    Abstract available


  341. GARCIA-CALLEJA JM , Rio CD, Souteyrand Y
    HIV infection in the Americas: improving strategic information to improve response.
    J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S1-3.
    PubMed     Text format     Related articles   


  342. ESHUN-WILSON I , Plas HV, Prozesky HW, Zeier MD, et al
    Combined antiretroviral treatment initiation during hospitalization: outcomes in South African adults.
    J Acquir Immune Defic Syndr. 2009;51:105-6.
    PubMed     Text format     Related articles   


    April 2009
  343. SHLAY JC , Sharma S, Peng G, Gibert CL, et al
    The Effect of Individual Antiretroviral Drugs on Body Composition in HIV-Infected Persons Initiating Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  344. CRUM-CIANFLONE NF , Hullsiek KH, Marconi V, Weintrob A, et al
    The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  345. ELLIS GM , Page LC, Burman BE, Buskin S, et al
    Increased Detection of HIV-1 Drug Resistance at Time of Diagnosis by Testing Viral DNA With a Sensitive Assay.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  346. MARTINEZ E , Arranz JA, Podzamczer D, Lonca M, et al
    A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  347. OSTROW DG , Plankey MW, Cox C, Li X, et al
    Specific Sex Drug Combinations Contribute to the Majority of Recent HIV Seroconversions Among MSM in the MACS.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  348. TRUONG HM , Kellogg T, Louie B, Klausner J, et al
    Recent HIV-1 Infection Detection: Comparison of Incidence Estimates Derived by Laboratory Assays and Repeat Testing Data.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  349. KWON JA , Iversen J, Maher L, Law MG, et al
    The Impact of Needle and Syringe Programs on HIV and HCV Transmissions in Injecting Drug Users in Australia: A Model-Based Analysis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  350. FIFE KH , Wu JW, Squires KE, Watts DH, et al
    Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  351. TRIANT VA , Meigs JB, Grinspoon SK
    Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  352. ROBERTS SS , Martinez M, Covington DL Dr, Rode RA, et al
    Lopinavir/Ritonavir in Pregnancy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  353. ZETOLA NM , Bernstein KT, Wong E, Louie B, et al
    Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs.
    J Acquir Immune Defic Syndr. 2009;50:546-51.
    PubMed     Text format     Related articles    Abstract available


  354. PETERS L , Mocroft A, Soriano V, Rockstroh JK, et al
    Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.
    J Acquir Immune Defic Syndr. 2009;50:457-63.
    PubMed     Text format     Related articles    Abstract available


  355. HOWE R , Dillon S, Rogers L, Palmer B, et al
    Phenotypic and functional characterization of HIV-1-specific CD4+CD8+ double-positive T cells in early and chronic HIV-1 infection.
    J Acquir Immune Defic Syndr. 2009;50:444-56.
    PubMed     Text format     Related articles    Abstract available


  356. GOGA AE , Van Wyk B, Doherty T, Colvin M, et al
    Operational effectiveness of guidelines on complete breast-feeding cessation to reduce mother-to-child transmission of HIV: results from a prospective observational cohort study at routine prevention of mother-to-child transmission sites, South Africa.
    J Acquir Immune Defic Syndr. 2009;50:521-8.
    PubMed     Text format     Related articles    Abstract available


  357. EGGER S , Petoumenos K, Kamarulzaman A, Hoy J, et al
    Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD).
    J Acquir Immune Defic Syndr. 2009;50:513-20.
    PubMed     Text format     Related articles    Abstract available


  358. GANDHI M , Benet LZ, Bacchetti P, Kalinowski A, et al
    Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.
    J Acquir Immune Defic Syndr. 2009;50:482-91.
    PubMed     Text format     Related articles    Abstract available


  359. VAN GRIENSVEN J , Zachariah R, Rasschaert F, Reid T, et al
    Discordant immunologic and virologic responses to antiretroviral therapy and associated mortality in a large treatment program in Rwanda.
    J Acquir Immune Defic Syndr. 2009;50:556-8.
    PubMed     Text format     Related articles   


  360. STEBBING J , Wong N, Tan L, Scourfield A, et al
    The relationship between prolonged antiretroviral therapy and cryptogenic liver disease.
    J Acquir Immune Defic Syndr. 2009;50:554-6.
    PubMed     Text format     Related articles   


  361. READ JS , Mwatha A, Richardson B, Valentine M, et al
    Primary HIV-1 Infection Among Infants in Sub-Saharan Africa: HPTN 024.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  362. MIMIAGA MJ , Noonan E, Donnell D, Safren SA, et al
    Childhood Sexual Abuse Is Highly Associated With HIV Risk-Taking Behavior and Infection Among MSM in the EXPLORE Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  363. BICANIC T , Meintjes G, Rebe K, Williams A, et al
    Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis: A Prospective Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  364. THOMSON MM , Vinogradova A, Delgado E, Rakhmanova A, et al
    Molecular Epidemiology of HIV-1 in St Petersburg, Russia: Predominance of Subtype A, Former Soviet Union Variant, and Identification of Intrasubtype Subclusters.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  365. HIRBOD T , Kaldensjo T, Lopalco L, Klareskog E, et al
    Abundant and Superficial Expression of C-Type Lectin Receptors in Ectocervix of Women at Risk of HIV Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  366. LIM A , French MA, Price P
    CD4+ and CD8+ T Cells Expressing FoxP3 in HIV-Infected Patients Are Phenotypically Distinct and Influenced by Disease Severity and Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  367. DEJESUS E , Young B, Morales-Ramirez JO, Sloan L, et al
    Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  368. HELLERINGER S , Kohler HP, Frimpong JA, Mkandawire J, et al
    Increasing Uptake of HIV Testing and Counseling Among the Poorest in Sub-Saharan Countries Through Home-Based Service Provision.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  369. ANNAN NT , Nelson M, Mandalia S, Bower M, et al
    The Nucleoside Backbone Affects Durability of Efavirenz- or Nevirapine-Based Highly Active Antiretroviral Therapy in Antiretroviral-Naive Individuals.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  370. COSSARINI F , Galli L, Sagnelli C, Gianotti N, et al
    Survival of HIV-1 Infected Multidrug-Resistant Patients Recycling Enfuvirtide After a Previous Failure.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  371. SACHDEV DD , Zerhouni-Layachi B, Ortigoza M, Profy AT, et al
    The Differential Binding and Activity of PRO 2000 Against Diverse HIV-1 Envelopes.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  372. ARRIBAS JR , Delgado R, Arranz A, Munoz R, et al
    Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  373. LYIMO MA , Howell AL, Balandya E, Eszterhas SK, et al
    Innate Factors in Human Breast Milk Inhibit Cell-Free HIV-1 but Not Cell-Associated HIV-1 Infection of CD4+ Cells.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  374. SENSION M , Neto JL, Grinsztejn B, Molina JM, et al
    Improvement in Lipid Profiles in Antiretroviral-Experienced HIV-Positive Patients With Hyperlipidemia After a Switch to Unboosted Atazanavir.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  375. VIRGILI N , Fisac C, Martinez E, Ribera E, et al
    Proinflammatory Cytokine Changes in Clinically Stable, Virologically Suppressed, HIV-Infected Patients Switching From Protease Inhibitors to Abacavir.
    J Acquir Immune Defic Syndr. 2009;50:552-553.
    PubMed     Text format     Related articles   


  376. PERISSE AR , Schechter M, Blattner W
    Association Between Male Circumcision and Prevalent HIV Infections in Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2009;50:435-437.
    PubMed     Text format     Related articles   


  377. MASSE BR , Boily MC, Desai K
    Using mathematical modeling to bridge phase 3 microbicide trials with public health decision making.
    J Acquir Immune Defic Syndr. 2009;50:434-5.
    PubMed     Text format     Related articles   


  378. ROU K , Guan J, Wu Z, Li L, et al
    Demographic and Behavioral Factors Associated With HIV Testing in China.
    J Acquir Immune Defic Syndr. 2009;50:432-434.
    PubMed     Text format     Related articles   


  379. CALZA L , Pocaterra D, Pavoni M, Colangeli V, et al
    Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-Positive Patients Versus 51 HIV-Negative Healthy Controls.
    J Acquir Immune Defic Syndr. 2009;50:430-432.
    PubMed     Text format     Related articles   


  380. BANI-SADR F , Lapidus N, Rosenthal E, Gerard L, et al
    Gamma Glutamyl Transferase Elevation in HIV/Hepatitis C Virus-Coinfected Patients During Interferon-Ribavirin Combination Therapy.
    J Acquir Immune Defic Syndr. 2009;50:429-430.
    PubMed     Text format     Related articles   


  381. AMIEL C , Legoff J, Lescure FX, Coste-Burel M, et al
    Epstein-Barr Virus Load in Whole Blood Correlates With HIV Surrogate Markers and Lymphoma: A French National Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2009;50:427-429.
    PubMed     Text format     Related articles   


  382. UNGE C , Sodergard B, Ekstrom AM, Carter J, et al
    Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya.
    J Acquir Immune Defic Syndr. 2009;50:397-402.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  383. SIIKA AM , Nyandiko WM, Mwangi A, Waxman M, et al
    The Structure and Outcomes of a HIV Postexposure Prophylaxis Program in a High HIV Prevalence Setup in Western Kenya.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  384. MERCIER S , Gueye NF, Cournil A, Fontbonne A, et al
    Lipodystrophy and Metabolic Disorders in HIV-1-Infected Adults on 4- to 9-Year Antiretroviral Therapy in Senegal: A Case-Control Study.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  385. SOBELA F , Pepin J, Gbeleou S, Banla AK, et al
    A Tale of Two Countries: HIV Among Core Groups in Togo.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  386. HENDRICKSON SL , Kingsley LA, Ruiz-Pesini E, Poole JC, et al
    Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  387. RAISZADEH F , Hoover DR, Lee I, Shi Q, et al
    Plasma Homocysteine Is Not Associated With HIV Serostatus or Antiretroviral Therapy in Women.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  388. MUSINGUZI J , Kirungi W, Opio A, Montana L, et al
    Comparison of HIV Prevalence Estimates From Sentinel Surveillance and a National Population-Based Survey in Uganda, 2004-2005.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  389. EMMANUEL F , Archibald C, Razaque A, Sandstrom P, et al
    Factors Associated With an Explosive HIV Epidemic Among Injecting Drug Users in Sargodha, Pakistan.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  390. CUEVAS MT , Munoz-Nieto M, Thomson MM, Delgado E, et al
    HIV-1 Transmission Cluster With T215D Revertant Mutation Among Newly Diagnosed Patients From the Basque Country, Spain.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  391. CHOPRA M , Townsend L, Johnston L, Mathews C, et al
    Estimating HIV Prevalence and Risk Behaviors Among High-Risk Heterosexual Men With Multiple Sex Partners: Use of Respondent-Driven Sampling.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  392. BUSSMANN H , Wester CW, Thomas A, Novitsky V, et al
    Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  393. MAVANDADI S , Zanjani F, Ten Have TR, Oslin DW, et al
    Psychological Well-Being Among Individuals Aging With HIV: The Value of Social Relationships.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  394. NACHEGA JB , Hislop M, Nguyen H, Dowdy DW, et al
    Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  395. CROSS SJ , Rodman JH, Lindsey JC, Robbins BL, et al
    Abacavir and Metabolite Pharmacokinetics in HIV-1-Infected Children and Adolescents.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  396. BROTHERS CH , Hernandez JE, Cutrell AG, Curtis L, et al
    Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  397. PASSAES CB , Guimaraes ML, Fernandez SL, Lorete RD, et al
    Lack of Primary Mutations Associated With Integrase Inhibitors Among HIV-1 Subtypes B, C, and F Circulating in Brazil.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  398. SCHIFFER JT , Sterling T
    Response to "A Brazilian Experience in Response to Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis".
    J Acquir Immune Defic Syndr. 2009;50:341.
    PubMed     Text format     Related articles   


  399. LAWN SD , Wood R
    Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis: A Reply.
    J Acquir Immune Defic Syndr. 2009;50:341-342.
    PubMed     Text format     Related articles   


  400. SCHMALTZ CA , Lopes GS, Rolla VC
    A Brazilian Experience in Response to "Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis"
    J Acquir Immune Defic Syndr. 2009;50:340.
    PubMed     Text format     Related articles   


  401. AMOR A , Simon A, Salgado M, Rodes B, et al
    Lack of Significant Cross-Reactivity for HIV-2 Immunoblots in HIV-1-Infected Patients.
    J Acquir Immune Defic Syndr. 2009;50:339-40.
    PubMed     Text format     Related articles   


  402. AGHDASSI E , Bondar H, Salit IE, Tinmouth J, et al
    Assessment of Knowledge and Attitudes of Physicians Involved in the Care of HIV-Infected Patients With Respect to Nutrition and Nutritional Supplements.
    J Acquir Immune Defic Syndr. 2009;50:337-9.
    PubMed     Text format     Related articles   


  403. HARRIS M , Cote H, Ochoa C, Allavena C, et al
    A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2009;50:335-337.
    PubMed     Text format     Related articles   


  404. PAPASAVVAS E , Foulkes A, Li X, Kostman JR, et al
    Evidence of a Decrease in CD4 Recovery Once Back on Antiretroviral Therapy After Sequential >/=6 Weeks Antiretroviral Therapy Interruptions.
    J Acquir Immune Defic Syndr. 2009;50:334-335.
    PubMed     Text format     Related articles   


    February 2009
  405. RICCI E , Malacrida S, Zanchetta M, Montagna M, et al
    Role of beta-Defensin-1 Polymorphisms in Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  406. LIMA V , Harrigan R, Montaner JS
    Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  407. CRUM-CIANFLONE N , Dilay A, Collins G, Asher D, et al
    Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  408. INWANI I , Mbori-Ngacha D, Nduati R, Obimbo E, et al
    Performance of Clinical Algorithms for HIV-1 Diagnosis and Antiretroviral Initiation Among HIV-1-Exposed Children Aged Less Than 18 Months in Kenya.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  409. GATHE J , Silva BA, Cohen DE, Loutfy MR, et al
    A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 Weeks.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  410. LIMA VD , Harrigan R, Bangsberg DR, Hogg RS, et al
    The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  411. CHASOMBAT S , McConnell MS, Siangphoe U, Yuktanont P, et al
    National Expansion of Antiretroviral Treatment in Thailand, 2000-2007: Program Scale-Up and Patient Outcomes.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  412. SHAH S , Demissie M, Lambert L, Ahmed J, et al
    Intensified Tuberculosis Case Finding Among HIV-Infected Persons From a Voluntary Counseling and Testing Center in Addis Ababa, Ethiopia.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  413. SAMARAS K
    Prevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  414. REN Y , Nuttall JJ, Eley BS, Meyers TM, et al
    Effect of Rifampicin on Efavirenz Pharmacokinetics in HIV-Infected Children With Tuberculosis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  415. NOTTET HS , van Dijk SJ, Fanoy EB, Goedegebuure IW, et al
    HIV-1 Can Persist in Aged Memory CD4+ T Lymphocytes With Minimal Signs of Evolution After 8.3 Years of Effective Highly Active Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  416. SCHROECKSNADEL K , Winkler C, Sarcletti M, Romani N, et al
    Parameters of Soluble Immune Activation In Vivo Correlate Negatively With the Proliferative Capacity of Peripheral Blood Mononuclear Cells In Vitro in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  417. KAVASERY R , Galai N, Astemborski J, Lucas GM, et al
    Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MD.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  418. WALMSLEY S , Avihingsanon A, Slim J, Ward DJ, et al
    Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  419. CHEN MY , Millwood IY, Wand H, Poynten M, et al
    A Randomized Controlled Trial of the Safety of Candidate Microbicide SPL7013 Gel When Applied to the Penis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  420. KOWALSKI J , Gange SJ, Schneider MF, Tsai HL, et al
    Relationship of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 pol Gene.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  421. PODZAMCZER D , Olmo M, Sanz J, Boix V, et al
    Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  422. SAJADI MM , Constantine NT, Mann DL, Charurat M, et al
    Epidemiologic Characteristics and Natural History of HIV-1 Natural Viral Suppressors.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  423. CAILHOL J , Jourdain G, Coeur SL, Traisathit P, et al
    Association of Low CD4 Cell Count and Intrauterine Growth Retardation in Thailand.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  424. WANG L , Wang N, Wang L, Li D, et al
    The 2007 Estimates for People at Risk for and Living With HIV in China: Progress and Challenges.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  425. VAN DER STRATEN A , Shiboski S, Montgomery ET, Moore J, et al
    Patterns and Predictors of Adherence to Diaphragm Use in a Phase III Trial in Sub-Saharan Africa: A Trajectory Analysis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  426. DONAHOE RM , O'neil SP, Marsteller FA, Novembre FJ, et al
    Probable Deceleration of Progression of Simian AIDS Affected by Opiate Dependency: Studies With a Rhesus Macaque/SIVsmm9 Model.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  427. SKOWRON G , Spritzler JG, Weidler J, Robbins GK, et al
    Replication Capacity in Relation to Immunologic and Virologic Outcomes in HIV-1-Infected Treatment-Naive Subjects.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  428. GOETZ MB , Leduc R, Kostman JR, Labriola AM, et al
    Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  429. APUZZO LG , Vaida F, Gallant JE, Ernstrom KB, et al
    Tolerability and Efficacy of PI Versus NNRTI-Based Regimens in Subjects Receiving HAART During Acute or Early HIV Infection.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  430. CHANG LW , Alamo S, Guma S, Christopher J, et al
    Two-Year Virologic Outcomes of an Alternative AIDS Care Model: Evaluation of a Peer Health Worker and Nurse-Staffed Community-Based Program in Uganda.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  431. POLITCH JA , Mayer KH, Anderson DJ
    Depletion of CD4+ T Cells in Semen During HIV Infection and their Restoration following Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  432. HAAS DW , Koletar SL, Laughlin L, Kendall MA, et al
    Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  433. DE LA FUENTE JS , Granja V, Escobar I, de la Fuente EC, et al
    Study of the Gastrointestinal Tolerance of a New Tablet Formulation of the Lopinavir/Ritonavir Antiretroviral in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  434. DESQUILBET L , Margolick JB, Fried LP, Phair JP, et al
    Relationship Between a Frailty-Related Phenotype and Progressive Deterioration of the Immune System in HIV-Infected Men.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  435. FALSTER K , Petoumenos K, Chuah J, Mijch A, et al
    Poor Baseline Immune Function Predicts an Incomplete Immune Response to Combination Antiretroviral Treatment Despite Sustained Viral Suppression.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  436. FREW PM , Rio CD, Lu L, Clifton S, et al
    Understanding Differences in Enrollment Outcomes Among High-Risk Populations Recruited to a Phase IIb HIV Vaccine Trial.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  437. HELMS DJ , Weinstock HS, Mahle KC, Bernstein KT, et al
    HIV Testing Frequency Among Men Who Have Sex With Men Attending Sexually Transmitted Disease Clinics: Implications for HIV Prevention and Surveillance.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  438. MARTINSON N , Mohapi L, Bakos D, Gray GE, et al
    Costs of Providing Care for HIV-Infected Adults in an Urban HIV Clinic in Soweto, South Africa.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  439. MILANESE M , Segat L, Arraes LC, Garzino-Demo A, et al
    Copy Number Variation of Defensin Genes and HIV Infection in Brazilian Children.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  440. BANI-SADR F , Bedossa P, Rosenthal E, Merrien D, et al
    Does Early Antiretroviral Treatment Prevent Liver Fibrosis in HIV/HCV-Coinfected Patients?
    J Acquir Immune Defic Syndr. 2009;50:234-236.
    PubMed     Text format     Related articles   


  441. CAPETTI AF , Piconi S, Landonio S, Rizzardini G, et al
    Is Dual Therapy With Raltegravir and Protease Inhibitors a Feasible Option in Rescue Strategy in HIV-1 Infection?
    J Acquir Immune Defic Syndr. 2009;50:233-4.
    PubMed     Text format     Related articles   


  442. PATEL AK , Patel KK, Sharma R, Ranjan RR, et al
    Prevention of Mother-to-Child HIV Transmission Using 3-Drug Combination Antiretroviral Treatment: Observational Cohort in Clinical Practice Setting in India.
    J Acquir Immune Defic Syndr. 2009;50:231-3.
    PubMed     Text format     Related articles   


  443. HOLTGRAVE D , Hall HI, Rhodes PH, Wolitski R, et al
    Updated annual HIV transmission rates in the United States, 1977-2006.
    J Acquir Immune Defic Syndr. 2009;50:236-8.
    PubMed     Text format     Related articles   


  444. SULLIVAN SG , Ma W, Duan S, Li F, et al
    Attitudes towards circumcision among Chinese men.
    J Acquir Immune Defic Syndr. 2009;50:238-40.
    PubMed     Text format     Related articles   


    January 2009
  445. DING M , Tarwater P, Rodriguez M, Chatterjee R, et al
    Estimation of the Predictive Role of Plasma Viral Load on CD4 Decline in HIV-1 Subtype C-Infected Subjects in India.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  446. VERHOFSTEDE C , Vandekerckhove L, Eygen VV, Demecheleer E, et al
    CXCR4-Using HIV Type 1 Variants Are More Commonly Found in Peripheral Blood Mononuclear Cell DNA Than in Plasma RNA.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  447. CAO W , Jamieson BD, Hultin LE, Hultin PM, et al
    Premature Aging of T cells Is Associated With Faster HIV-1 Disease Progression.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  448. VELASCO M , Castilla V, Sanz J, Gaspar G, et al
    Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  449. VAN VONDEREN MG , Smulders YM, Stehouwer CD, Danner SA, et al
    Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  450. BUTLER LM , Osmond DH, Jones AG, Martin JN, et al
    Use of Saliva as a Lubricant in Anal Sexual Practices Among Homosexual Men.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  451. VIDELA S , Darwich L, Canadas MP, Paredes R, et al
    Epidemiological Data of Different Human Papillomavirus Genotypes in Cervical Specimens of HIV-1-Infected Women Without History of Cervical Pathology.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  452. MARU DS , Bruce RD, Walton M, Springer SA, et al
    Persistence of Virological Benefits Following Directly Administered Antiretroviral Therapy Among Drug Users: Results From a Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  453. LEVIN MJ , Anderson JP, Seage GR 3rd, Williams PL, et al
    Short-Term and Long-Term Effects of Highly Active Antiretroviral Therapy on the Incidence of Herpes Zoster in HIV-Infected Children.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  454. SPAGNUOLO V , Gianotti N, Seminari E, Galli L, et al
    Changes in Darunavir/r Resistance Score After Previous Failure to Tipranavir/r in HIV-1-Infected Multidrug-Resistant Patients.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  455. DELUCA A , Chaisson RE, Martinson NA
    Intensified Case Finding for Tuberculosis in Prevention of Mother-to-Child Transmission Programs: A Simple and Potentially Vital Addition for Maternal and Child Health.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles   


  456. VAN GEERTRUYDEN JP , Mulenga M, Chalwe V, Michael N, et al
    Impact of HIV-1 Infection on the Hematological Recovery After Clinical Malaria.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  457. FONTAS E , Kousignian I, Pradier C, Duvivier C, et al
    Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients; Results From FHDH ANRS CO4.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  458. WONG LH , Rooyen HV, Modiba P, Richter L, et al
    Test and Tell: Correlates and Consequences of Testing and Disclosure of HIV Status in South Africa (HPTN 043 Project Accept).
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  459. DELVAUX T , Elul B, Ndagije F, Munyana E, et al
    Determinants of Nonadherence to a Single-Dose Nevirapine Regimen for the Prevention of Mother-to-Child HIV Transmission in Rwanda.
    J Acquir Immune Defic Syndr. 2009.
    PubMed     Text format     Related articles    Abstract available


  460. MUGAVERO MJ , Lin HY, Allison JJ, Giordano TP, et al
    Racial disparities in HIV virologic failure: do missed visits matter?
    J Acquir Immune Defic Syndr. 2009;50:100-8.
    PubMed     Text format     Related articles    Abstract available


  461. BAUM MK , Rafie C, Lai S, Sales S, et al
    Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
    J Acquir Immune Defic Syndr. 2009;50:93-9.
    PubMed     Text format     Related articles    Abstract available


  462. POWELL RL , Urbanski MM, Burda S, Kinge T, et al
    High frequency of HIV-1 dual infections among HIV-positive individuals in Cameroon, West Central Africa.
    J Acquir Immune Defic Syndr. 2009;50:84-92.
    PubMed     Text format     Related articles    Abstract available


  463. MIMIAGA MJ , Case P, Johnson CV, Safren SA, et al
    Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.
    J Acquir Immune Defic Syndr. 2009;50:77-83.
    PubMed     Text format     Related articles    Abstract available


  464. NOVITSKY V , Woldegabriel E, Kebaabetswe L, Rossenkhan R, et al
    Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.
    J Acquir Immune Defic Syndr. 2009;50:65-76.
    PubMed     Text format     Related articles    Abstract available


  465. ABERG JA
    Cardiovascular complications in HIV management: past, present, and future.
    J Acquir Immune Defic Syndr. 2009;50:54-64.
    PubMed     Text format     Related articles    Abstract available


  466. GIBERT CL , Shlay JC, Sharma S, Bartsch G, et al
    Racial differences in changes of metabolic parameters and body composition in antiretroviral therapy-naive persons initiating antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2009;50:44-53.
    PubMed     Text format     Related articles    Abstract available


  467. GANDHI NR , Moll AP, Lalloo U, Pawinski R, et al
    Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study.
    J Acquir Immune Defic Syndr. 2009;50:37-43.
    PubMed     Text format     Related articles    Abstract available


  468. JOYCE VR , Barnett PG, Bayoumi AM, Griffin SC, et al
    Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease.
    J Acquir Immune Defic Syndr. 2009;50:27-36.
    PubMed     Text format     Related articles    Abstract available


  469. MADEC Y , Boufassa F, Avettand-Fenoel V, Hendou S, et al
    Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort.
    J Acquir Immune Defic Syndr. 2009;50:19-26.
    PubMed     Text format     Related articles    Abstract available


  470. KASSAYE S , Johnston E, McColgan B, Kantor R, et al
    Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2009;50:9-18.
    PubMed     Text format     Related articles    Abstract available


  471. LUO M , Liu H, Zhuang K, Liu L, et al
    Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.
    J Acquir Immune Defic Syndr. 2009;50:1-8.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  472. PERCIACCANTE A , Zanette G, Donadon V
    Type 2 diabetes mellitus and increased prevalence of hepatocarcinoma in HIV-infected population.
    J Acquir Immune Defic Syndr. 2008;49:573.
    PubMed     Text format     Related articles   


  473. COHAN D , Sarnquist C, Gomez E, Feakins C, et al
    Increased uptake of HIV testing with the integration of nurse-initiated HIV testing into routine prenatal care.
    J Acquir Immune Defic Syndr. 2008;49:571-3.
    PubMed     Text format     Related articles   


  474. DJOMAND G , Beyrer C, Buchbinder S
    Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy.
    J Acquir Immune Defic Syndr. 2008;49:570.
    PubMed     Text format     Related articles   


  475. GODY JC , Charpentier C, Mbitikon O, Si-Mohamed A, et al
    High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations.
    J Acquir Immune Defic Syndr. 2008;49:566-9.
    PubMed     Text format     Related articles   


  476. DE MEYER S , Hill A, Picchio G, DeMasi R, et al
    Influence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial.
    J Acquir Immune Defic Syndr. 2008;49:563-4.
    PubMed     Text format     Related articles   


  477. KIDDER DP , Wolitski RJ, Pals SL, Campsmith ML, et al
    Housing status and HIV risk behaviors among homeless and housed persons with HIV.
    J Acquir Immune Defic Syndr. 2008;49:451-5.
    PubMed     Text format     Related articles    Abstract available


  478. LATKIN CA , Buchanan AS, Metsch LR, Knight K, et al
    Predictors of sharing injection equipment by HIV-seropositive injection drug users.
    J Acquir Immune Defic Syndr. 2008;49:447-50.
    PubMed     Text format     Related articles    Abstract available


  479. FRIEDMAN SR , Bolyard M, Khan M, Maslow C, et al
    Group sex events and HIV/STI risk in an urban network.
    J Acquir Immune Defic Syndr. 2008;49:440-6.
    PubMed     Text format     Related articles    Abstract available


  480. CHIGWEDERE P , Seage GR 3rd, Gruskin S, Lee TH, et al
    Estimating the lost benefits of antiretroviral drug use in South Africa.
    J Acquir Immune Defic Syndr. 2008;49:410-5.
    PubMed     Text format     Related articles    Abstract available


  481. DELANY S , Rosas R, Mlaba N, Clayton T, et al
    Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions.
    J Acquir Immune Defic Syndr. 2008;49:406-9.
    PubMed     Text format     Related articles    Abstract available


  482. HSIEH YH , Rothman RE, Bartlett JG, Yang S, et al
    HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections.
    J Acquir Immune Defic Syndr. 2008;49:398-405.
    PubMed     Text format     Related articles    Abstract available


  483. NJAMNSHI AK , Djientcheu Vde P, Fonsah JY, Yepnjio FN, et al
    The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaounde-Cameroon.
    J Acquir Immune Defic Syndr. 2008;49:393-7.
    PubMed     Text format     Related articles    Abstract available


  484. TIEN PC , Schneider MF, Cole SR, Levine AM, et al
    Antiretroviral therapy exposure and insulin resistance in the women's interagency HIV study.
    J Acquir Immune Defic Syndr. 2008;49:369-76.
    PubMed     Text format     Related articles    Abstract available


  485. KNOX TA , Oleson L, von Moltke LL, Kaufman RC, et al
    Ritonavir greatly impairs CYP3A activity in HIV infection with chronic viral hepatitis.
    J Acquir Immune Defic Syndr. 2008;49:358-68.
    PubMed     Text format     Related articles    Abstract available


  486. USUGA X , Montoya CJ, Landay AL, Rugeles MT, et al
    Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2008;49:348-57.
    PubMed     Text format     Related articles    Abstract available


  487. PATTANAPANYASAT K , Phuang-Ngern Y, Sukapirom K, Lerdwana S, et al
    Comparison of 5 flow cytometric immunophenotyping systems for absolute CD4+ T-lymphocyte counts in HIV-1-infected patients living in resource-limited settings.
    J Acquir Immune Defic Syndr. 2008;49:339-47.
    PubMed     Text format     Related articles    Abstract available


  488. DE BOER-VAN DER KOLK IM , Sprangers MA, van der Ende M, Schreij G, et al
    Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.
    J Acquir Immune Defic Syndr. 2008;49:460-2.
    PubMed     Text format     Related articles   


    November 2008
  489. ROBERTSON SM , Maldarelli F, Natarajan V, Formentini E, et al
    Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects.
    J Acquir Immune Defic Syndr. 2008.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: